WO1995018149A1 - Novel lectin and process for producing the same - Google Patents

Novel lectin and process for producing the same Download PDF

Info

Publication number
WO1995018149A1
WO1995018149A1 PCT/JP1994/002140 JP9402140W WO9518149A1 WO 1995018149 A1 WO1995018149 A1 WO 1995018149A1 JP 9402140 W JP9402140 W JP 9402140W WO 9518149 A1 WO9518149 A1 WO 9518149A1
Authority
WO
WIPO (PCT)
Prior art keywords
lectin
erythrocytes
genus
gel filtration
derived
Prior art date
Application number
PCT/JP1994/002140
Other languages
French (fr)
Japanese (ja)
Inventor
Akihiro Kawakubo
Hiroyuki Makino
Masanori Ninomiya
Nozomu Bitou
Original Assignee
Marine Greens Laboratory Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marine Greens Laboratory Co., Ltd. filed Critical Marine Greens Laboratory Co., Ltd.
Priority to JP7516400A priority Critical patent/JP2895962B2/en
Publication of WO1995018149A1 publication Critical patent/WO1995018149A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Definitions

  • the present invention relates to a novel lectin and a method for producing the same.
  • the present invention relates to a novel lectin derived from seaweed, in particular, a seaweed belonging to the genus Kirinsai (genus Euchea or Kappaphycus), and a method for producing the same.
  • Lectin is a general term for sugar-binding proteins or glycoproteins that are not immunological products and are found in animals, plants, bacteria, etc.
  • lectins derived from land plants have long been known as hemagglutinins.
  • several lectins have been found not only in land plants but also in seaweeds, and some of these lectins not only recognize erythrocytes but also recognize complex carbohydrates. It was discovered (Hori et al., Botani ca Marina Vol. 29, pp. 323-328, 1986), and its physiological significance and properties have attracted attention.
  • lectins derived from animals and plants are sold as research reagents, and development of other practical applications is under consideration, but for seaweed lectins, lectins derived from the genus Mill are sold as two kinds of reagents. It is only.
  • the seaweed of the genus Kirinsai has only been used as a raw material for carrageenan algae and seaweed salad, and the active ingredients contained therein have not been developed except for the use of polysaccharides. Therefore, from the viewpoint of effective utilization of such seaweed resources, the technology of producing high value-added substances such as lectins from these seaweeds is very useful. Disclosure of the invention
  • the present inventors have collected a wide variety of seaweeds and conducted intensive research on lectins in seaweeds.As a result, they have found novel lectins in seaweeds of the genus Kirinsai and established a method for their production. Thus, the present invention has been completed.
  • SDS sodium dodecyl sulfate having a molecular weight of about 29,000 by electrophoresis
  • amino acid sequence of the N-terminal region is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (X is Gin or Lys),
  • Trypsin-treated ⁇ has specific agglutinating activity on heron erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes,
  • the present invention provides a novel lectin characterized by exhibiting binding specificity to phytin, ash mouth phytin, thyroglobulin, and yeast mannan. Further, the present invention provides a method for producing the above-mentioned novel lectin, that is, using seaweed belonging to the genus Kirinsai as a raw material, extracting it with an extraction solvent selected from a buffer solution and a solvent-water mixture, and extracting the extract with solvent precipitation and gelation.
  • An object of the present invention is to provide a method for producing a novel lectin, which is characterized in that the lectin is separated and purified by filtration, preferably further through one step of ion exchange chromatography.
  • the novel lectin of the present invention has the above-mentioned characteristics (a) to (g).
  • the lectin of the present invention exhibits a molecular weight of about 25,000 by gel filtration, and a molecular weight of about 29,000 by SDS electrophoresis.
  • the determination of the molecular weight by the gel filtration method in the present invention is performed by using a gel filtration color for molecular weight measurement.
  • HPLC High-performance liquid chromatography using HPLC [hereinafter referred to as HPLC, conditions; column: Superdex 75 HR (10x300 mm), eluent: 0.05 M phosphate buffer (pH 7.2) containing 0.1 M NaCl] .
  • standard proteins with known molecular weights in advance (aldolase (MW158, 000), transferrin (MW800, 000), and serum albumin (MW68, 000)) , Ovalbumin (MW 43,000), carbonic anhydrase (MW32, OOiOS-lactoglobulin (MW18, 00), aprotinin (MW 6,500), vitamin B12 (MW 1, 355))] can be used to determine the molecular weight of the lectin of the present invention.
  • SDS electrophoresis means polyacrylamide gel electrophoresis (hereinafter referred to as SDS-PAGE) performed in the presence of sodium dodecyl sulfate.
  • SDS-PAGE polyacrylamide gel electrophoresis
  • the determination of the molecular weight by the SDS electrophoresis in the present invention can be carried out according to the SDS-PAGE by Laeimli's method (Nature, 227, 680, 1976). Specifically, the lectin of the present invention was subjected to heat treatment at 100 ° C.
  • Albumin (MW 66,000), ovalbumin (MW 45,000), glyceraldehyde-13-phosphate dehydrogenase (MW36,000) from cow heron muscle, cow Erythrocyte-derived carbonic anhydrase (MW290,000), bovine kidney trypsinogen (MW24,000), soybean-derived trypsin inhibitor (MW200,100), milk-derived milk —Detection by staining with lactoglobulin (MW 14,200)) And the molecular weight can be determined.
  • the lectin of the present invention showed a molecular weight of about 25,000 by the above-mentioned gel filtration method, and a monomer having a molecular weight of about 29,000 by the above-mentioned SDS electrophoresis method. It seems to be the body.
  • the lectin of the present invention has a PI of 4.5 to 5.7 when its isoelectric point is measured by polyacrylamide gel isoelectric focusing.
  • a PI of 4.5 to 5.7 when its isoelectric point is measured by polyacrylamide gel isoelectric focusing.
  • at least one selected from p1 4.75, pI4.95, pI5.05, pI5.20 and pI5.50 in the polyacrylamide gel isoelectric focusing method is used. Both of them have the same isoelectric point.
  • Determination of isoelectric point by polyacrylamide gel isoelectric focusing in the present invention is carried out according to a conventional method, using 2% Ampholine (pH 4 to 6.5) as an amphoteric carrier and using a 7% polyacrylamide gel. It can be performed by running at 460 V constant voltage for 20 hours.
  • the lectin of the present invention is obtained by a phenol-sulfuric acid method using glucose as a measurement standard sample at least CDubois.M., Gilles.KA, Hamilton, JK, Rebers.PA and Smith, F. (1956), Anal.Chem. 28, 357] shows that the sugar content is 0% within the experimental error, and from this it is determined that the sugar chain is not present.
  • the sugar content can be determined by the following equation.
  • the lectin of the present invention has a Gly-Arg-Tyr-Thr-Val-Gln-Asn-Gln-Trp-Gly or Gly-Arg-Tyr-Thr-Val-Lys-Asn-Gln-Trp-Gly in the N-terminal region. It is a protein having the following amino acid sequence:
  • the amino acid sequence can be analyzed using an amino acid analyzer such as Applied Biosystems 477A PTH Analyzer.
  • the lectin included in the present invention has an amino acid sequence consisting of 10 amino acid residues in the N-terminal region, except that the sixth amino acid residue from the N-terminal side is glutamine or lysine. Are characterized by having a common amino acid sequence. Furthermore, in addition to the features of the amino acid sequence of the N-terminal region, the lectins included in the present invention Since the molecular weights obtained by SDS electrophoresis or gel filtration are the same and their isoelectric points differ from pi 4.5 to pI 5.7, some amino acid residues (at least (The sixth amino acid residue from the N-terminal side) are considered to be different from each other.
  • the lectin of the present invention has a feature of specifically agglutinating ovine erythrocytes, trypsin-treated ⁇ egret erythrocytes and trypsin-treated whiskery erythrocytes, and, on the other hand, ego erythrocytes, ⁇ red erythrocytes, goose erythrocytes, and trypsin-treated ⁇ red blood cells. It has no agglutinating activity on either erythrocytes or trypsin-treated goose erythrocytes.
  • the agglutinating activity on these erythrocytes can be determined by measuring using a serial two-fold dilution method [B0TANICA MAR INA, Vol. 31, pp. 133-138, (1988)].
  • the lectin of the present invention does not show specific binding to monosaccharides and oligosaccharides, has binding specificity to asialophetin, phytin, thyroglobulin, and yeast mannan, and has an ⁇ 1-acid It also has weak binding specificity for glycoproteins. Among them, thyroglobulin and distmannan have particularly strong binding specificities. That is, since thyroglobulin and yeast mannan are rich in high mannose type sugar chains among glycoproteins, the lectin of the present invention recognizes ⁇ -glycoside type sugar chains in glycoproteins, and In particular, it is understood that the high Mannos type is strongly recognized.
  • the sugar-binding specificity of the lectin can prevent the agglutination of the erythrocytes by using a specific erythrocyte which can specifically agglutinate the lectin, for example, a sheep erythrocyte, a trypsin-treated heron erythrocyte or a tribcine-treated shed erythrocyte. It can be confirmed by examining sugars and glycosides.
  • the lectin of the present invention has blastogenic activity on mouse and human lymphocytes (see Test Example 1).
  • the measurement of lymphocyte transformation activity of the lectins since the simple and certain objective results, the lectin of the present invention was added to mouse lymphocytes or human lymphocytes were cultured, into cells 3 .eta.
  • a method of determining thymidine incorporation by radioactivity measurement is preferably used.
  • the lectin of the present invention having such an effect is clinically useful for in vitro detection and evaluation of cell-mediated immunity.
  • the lectin of the present invention is not particularly limited in its origin, etc., as long as it has the above characteristics, but is preferably a marine algae, especially a marine genus belonging to the genus Kirinsai (genus Eucheuma or Kappaphycus). It is obtained by separation and purification.
  • the seaweed that can be a source of the lectin of the present invention preferably includes seaweeds of the genus Kirinsai (genus Eucheuma or Kappaphycus) that grow in Japan and all over the world.
  • seaweed which had been classified as the red alga Kirinsai genus (scientific name: Eucheuma genus), has recently been separated into Euche genus a and Kappaphycus genus.
  • the genus Kirinsai refers to a genus of the genus Euche a and the genus Kappaphycus. Further, in the present specification, when each genus name is distinguished and described, the genus name is abbreviated to E. for the genus Eucheun ⁇ and the genus name is K. for Kappaphycus.
  • seaweeds belonging to the genus Kirinsai used in the present invention include, for example, togekirinsai (E. serra), euphorma kottonii cottoni i), katamenkirin rhinocerat gelat inae), amasakirinsai amakusaensis), ⁇
  • Seaweed belonging to the genus Kappaphycus such as K. cottoni i, K. striatum ⁇ K. alvarezi i, and K. arnoldi i.
  • Preferable ones are P. serra), E. plumeria cottoni i), E. gelat inae and A. makusaensis.
  • the original algae for carrageenan production which was conventionally called ⁇ cottoni i, has recently been separated from Euche genus and proposed to be called Kappaphycus procrusteanum (SEAWEED CULTAVATION AND MARINE RANCHING, 75-88). P. 1993), but in the present invention, it will be referred to as E. cottonii.
  • the lectin of the present invention can be isolated and obtained from these seaweeds by appropriately combining known extraction methods, separation methods, purification methods, and the like. Representative production methods are described in detail below. I do.
  • the method for producing a lectin of the present invention comprises extracting seaweed, particularly seaweed belonging to the genus Kirinsai, with an extraction solvent selected from a buffer solution and a solvent-water mixture, and subjecting the extracted solution to solvent precipitation and gel filtration.
  • This method is characterized in that it is separated and purified, and if necessary, ion exchange chromatography may be performed.
  • the seaweeds used in the method preferably include seaweeds belonging to the genus Kirinsai (genus Eucheuma or Kappaphycus).
  • Kirinsai genus Eucheuma or Kappaphycus.
  • seaweed belonging to the genus Kappaphycus such as cupresoideunu E. spinosum, E. arnoldi is E. alvarezi i, E. striatum, etc. Is mentioned. Judging from the content of lectin and the availability of lectin, etc., it is preferable to use serra).
  • ⁇ ⁇ cotton cotton cotton, ⁇ ⁇ ⁇ ⁇ E E E cotton, E. denticulat ⁇ , E. spinosunu E. alvarezii, K. procrusteanum and cottoni i ⁇ alvarezii and particularly preferred are E. serra, E. serra, C. cottonii and (E. gelat inae) and E. amakusaensis.
  • seaweeds In the production of lectin, it is preferable to first collect these seaweeds, wash them well with seawater, freeze-dry them, and then pulverize them into seaweed powder.
  • the obtained seaweed powder is extracted using a suitable extraction solvent.
  • any of various buffers, various organic solvents that can be mixed with water, or a mixed solution of an organic solvent and water can be used.
  • a mixed solution of a buffer or an organic solvent and water is used.
  • the buffer include, but are not particularly limited to, various known buffers, and a buffer having a buffering ability in the pH range of 3 to 10 is preferable.
  • organic solvent acetone, methanol, ethanol or isopropanol is preferable. Among them, it is particularly preferable to use a mixed solution of ethanol and water of 10% to 40%.
  • a 25% ethanol aqueous solution is added to seaweed powder, and extraction is performed while maintaining the temperature as low as necessary, to obtain a seaweed extract.
  • the seaweed extract is separated into a supernatant and an extraction residue by filtration or centrifugation, and the supernatant is recovered as an extract containing the lectin of the present invention (primary extract) ).
  • a 25% aqueous solution of ethanol may be added again to the extraction residue to perform a second extraction and collect as an extract containing the lectin of the present invention (secondary extract).
  • the extract containing the lectin of the present invention is subjected to a solvent precipitation operation, for example, salting out with ammonium sulfate (hereinafter referred to as ammonium sulfate salting out) or precipitation with an organic solvent. Can be recovered.
  • a solvent precipitation operation for example, salting out with ammonium sulfate (hereinafter referred to as ammonium sulfate salting out) or precipitation with an organic solvent.
  • Ammonium sulfate salting out can be carried out by a conventional method, and is usually carried out by collecting a fraction precipitated with 0 to 80% saturated ammonium sulfate, preferably 20 to 80% saturated ammonium sulfate.
  • Precipitation with an organic solvent can be carried out by an ordinary method using any water-soluble organic solvent, regardless of the type of extraction solvent used in the previous extraction operation.
  • Preferred organic solvents include acetone, methanol, ethanol, isopropanol and the like, with ethanol being particularly preferred. For example, when extracting with an ethanol-water mixture, if the final concentration of ethanol is adjusted to 70% or more by adding an appropriate amount of cold ethanol, the protein containing the lectin of the present invention precipitates as a precipitate. .
  • the precipitate fraction obtained by these methods is collected by a conventional method, suspended in a buffer solution (PH 6 to 8), dialyzed against the buffer solution, and the solvent is removed to obtain a crude solution of the lectin of the present invention. Can be obtained.
  • the lectin of the present invention can be easily isolated and purified by subjecting the crude lectin solution from which the solvent has been removed to gel filtration.
  • the filler used in the gel filtration it is preferable to use various products having an exclusion limit molecular weight of 100,000 or less.
  • Preferred is gel filtration column chromatography using a column filled with such a packing material.
  • the eluent is not particularly limited as long as it does not affect the physical and biochemical properties of the lectin.For example, the eluent contains a salt of about 0 to 1 M. Phosphate buffer (pH 6 to 9).
  • a crude lectin solution is applied to a column for gel filtration, and then the eluate is supplied while the eluent is supplied. It can be carried out by monitoring the agglutinating activity of each fraction on erythrocytes using erythrocytes showing activity.
  • the agglutinating activity on erythrocytes can be determined by the serial two-fold dilution method CBOTANICA MARINA, Vol. 31, pp. 133-138, (1988)].
  • the lectin fraction of the present invention a fraction in which the maximum peak of ultraviolet absorption (280 nm) coincides with the peak of agglutination activity for erythrocytes.
  • the lectin fraction can be obtained from both the primary extract and the secondary extract described above.
  • a lectin purified to 90% or more purity which can be confirmed as a single band in SDS electrophoresis, can be obtained.
  • a lectin purified to a purity of 99% or more can be produced and obtained by such an operation.
  • the lectin produced by the above method has the following characteristics irrespective of the type of seaweed used as a starting material.
  • amino acid sequence of the N-terminal region is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (X is Gin or Lys)
  • Trypsin-treated ⁇ has specific agglutinating activity on heron erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes,
  • the lectin fraction obtained by the above gel filtration method can be further subjected to ion exchange chromatography, preferably anion exchange chromatography, if necessary.
  • the lectin fraction after gel filtration is subjected to anion-exchange chromatography using a carrier having a weak anion-exchange group such as getylaminoethyl (DEAE) group.
  • a carrier having a weak anion-exchange group such as getylaminoethyl (DEAE) group.
  • the lectin fraction obtained by the gel filtration method can be further fractionated into a plurality of fractions having only slightly different isoelectric points according to the lectin contained in the fraction.
  • the lectin fraction obtained by the gel filtration method contains a lectin having a plurality of isoelectric points, it should be isolated and purified into individual lectins having respective isoelectric points by the ion exchange chromatography. Can be.
  • the lectin that can be produced by such a method is characterized in terms of molecular weight, presence or absence of sugar chains, amino acid sequence, hemagglutinating activity and sugar-binding specificity, by various properties of the lectin obtained by gel filtration ((a), (b) and (d) to (g)), and has the characteristic that the isoelectric point measured by the isoelectric point electrophoresis method indicates one point in the range of PI 4.5 to pI 5.7. .
  • the number of lectins contained in the lectin fraction obtained by the gel filtration method varies depending on the type of giraffe used as a raw material, and the isoelectric point of each lectin contained also varies depending on the type of giraffe. There is a slight difference between 5 and pi 5.7.
  • a lectin exhibiting an isoelectric point of pi 4.75 or pi 4.95 by isoelectric focusing If the lectin with pI 5.05 or pi 5.20 is derived from the Japanese rhinoceros or linden, it will have pi 4.95, pi 5.20 or pi 5.50 Lectin Is obtained.
  • Lectins obtained by gel filtration, lectins obtained by anion-exchange chromatography, and mixtures of these lectins were confirmed to have blastogenic activity on mouse and human lymphocytes, respectively. It has been.
  • the lectin of the present invention is a novel lectin having different physicochemical properties from conventional lectins, and also different biochemical properties such as specificity of sugar chain binding.
  • PHA phytohemagglutinin
  • concanapalin A etc.
  • they utilize their unique sugar chain binding specificity to test reagents, immunomodulators, and specific adsorbents for separation and analysis of carbohydrates.
  • it is expected to be applied to various other fields using its affinity for sugar chains.
  • the lectin of the present invention since it has a blastogenic activity on lymphocytes, it can be used in mammals such as humans, mice, dogs, dogs, and mice, for example, when transplanting organs or bone marrow. Used as an inhibitor of rejection, an antitumor agent capable of exerting an antitumor effect through lymphocyte activation, or as a preventive or therapeutic agent for autoimmune diseases such as rheumatoid arthritis, immunodeficiency, etc., or as a reagent in medicine or pharmaceuticals be able to.
  • the lectin of the present invention may be used alone, or as a mixture of a plurality of substances having different isoelectric points, mixed with a pharmaceutically acceptable carrier, excipient, diluent, etc., to give powders, capsules, tablets, ointments, etc. And administered to patients.
  • a freeze-dried preparation may be prepared by a means known per se.
  • it can also be used as cosmetics.
  • the lectin of the present invention is used in an amount of 0.1 to 100 mg / day, which is appropriately selected in consideration of a patient's disease, symptoms, weight, sex, age, etc., usually per adult. Is administered once to several times a day.
  • such a useful lectin can be separated and purified from seaweeds, particularly seaweeds belonging to the genus Kirinsai, by a simpler method to obtain a large amount thereof, resulting in industrial production of lectins. be able to.
  • FIG. 1 shows a chromatogram obtained by subjecting a crude lectin solution derived from Rhododendron rhizome to gel filtration chromatography.
  • FIG. 2 shows a chromatogram obtained by subjecting an active fraction (lectin ES 0) of a crude lectin solution derived from Pterodactylus to a DEAE ion exchange chromatography after gel filtration chromatography.
  • FIG. 3 shows a chromatogram obtained by subjecting the active fraction (lectin EC0) of the crude lectin solution derived from Yukiyama Cotney after gel filtration chromatography to DEAE ion exchange chromatography.
  • FIG. 1 shows a chromatogram obtained by subjecting a crude lectin solution derived from Rhododendron rhizome to gel filtration chromatography.
  • FIG. 2 shows a chromatogram obtained by subjecting an active fraction (lectin ES 0) of a crude lectin solution derived from Pterodactylus to
  • FIG. 4 shows a chromatogram of an active fraction (lectin EG0) obtained by gel filtration chromatography of a crude lectin solution derived from Rhinoceros oryzae, which was applied to DEAE ion exchange chromatography.
  • FIG. 5 shows a chromatogram of an active fraction (lectin EA0) after gel filtration chromatography of a crude lectin solution derived from Acacia officinalis subjected to DE AE ion exchange chromatography.
  • “—” means absorbance (280 nm), and ...... means the hemagglutination activity titer.
  • the recovery rate from the extract was 95%, calculated from the agglutinating activity on erythrocytes.
  • 96 Omg of lectin derived from Rhododendron was obtained from 100 g of the freeze-dried powder.
  • the lectin derived from P. terrestris purified by gel filtration chromatography was designated ES0 and used in the following experiments.
  • Fig. 1 shows the above results.
  • a lectin showing a single band was obtained by SDS electrophoresis (about the same conditions as above) of about 174 mg from the primary extract and about 2 Omg from the secondary extract. ) And (6) were 95% and 97% by DEAE ion exchange chromatography and analytical gel filtration chromatography, respectively. The recovery from the extract was 90%, calculated from the agglutinating activity on erythrocytes. Less than 20 mg of lectin was recovered from 100 g of freeze-dried Yuki Yuma cotney powder. This lectin purified by gel filtration chromatography was designated as EC0 and used in the following experiments.
  • ES 0 obtained by gel filtration chromatography was first desalted and buffered by dialyzing it against a 20 mM sodium carbonate buffer (pH 9.5).
  • Eluent A (20 mM sodium carbonate buffer, pH 9.5) and eluent were used as the eluent, using TSK-ge 1 DEAE-5 PW (manufactured by Tosoichi Co., Ltd., size: 7.5 x 7.5 cm).
  • Solution B (20 mM sodium carbonate buffer, pH 9.5 + 0.5 M sodium chloride) was used.
  • the buffered ES 0 is applied to the column equilibrated with eluent A.
  • Isoelectric points of ES 0, ES 1 and ES 2 were measured by polyacrylamide gel isoelectric focusing. Specifically, 2% Ampholine, pH 4.0 to 6.5 was used as an amphoteric carrier, and electrophoresis was performed in a 7% polyacrylamide gel at a constant voltage of 460 V for 20 hours. As a running buffer, a 0.01 M phosphoric acid solution was used on the anode side, and a 0.01 M sodium hydroxide solution was used on the cathode side. After electrophoresis, the gel was fixed and stained to detect proteins.
  • ES1 was 0.01% and ES2 was 0.02%, and it is considered that the lectin derived from Togekirinsai has no sugar chain.
  • ES0 reproducible data was not obtained. This is presumably because saccharides unrelated to the lectin may remain slightly mixed during the purification process.
  • Lectins derived from Papaver rhinoceros rhinoceros (ES 0, ES 1 and ES 2), lectins derived from Yuki-Yuma Cotney (EC 0, EC 1 and EC 2), and lectins derived from Papaver rhinoceros rhinoceros (R. EG 3) -derived lectin and Amaxilla lectin-derived lectins (EA 0, EA 1, EA 2 and EA 3) were applied to an Applied Biosystems 477A PTH analyzer, and amino acids from the N-terminus to 1q residue were analyzed. The sequence was analyzed.
  • the amino acid sequence of 10 residues is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly, and the sixth amino acid from the N-terminal indicated by X is glumin or lysine. Were identical except for
  • Lectins derived from Papaver rhinoceros rhinoceros (ES 0, ES I and ES 2), lectins derived from Yucca Lacii (ECO, EC 1 and EC 2), and lectins derived from Papaver rhinoceros rhinoceros rhinoceros (Rice chinensis) (EG0, EG1, EG2 and EG3)
  • the agglutinating activity on various erythrocytes was measured for each of the lectin and the lectins (EA0, EA1, EA2 and EA3) derived from Rhododendron.
  • Lectins derived from Rhododendron ginseng (ES 0 ES 1 and ES 2), Lectins derived from Echinoma crispina (EC 0 EC 1 and EC 2), and Lectins derived from Lactobacillus reticulata (EG0 EG 1 EG2 and EG3) And the lectins (EA0 EA1 EA2 and EA3) derived from Acacia chinensis were examined for their sugar-binding specificity. Specifically, first prepare various concentration solutions of various monosaccharides, oligosaccharides and glycosides listed in Table 2, add each lectin adjusted to the minimum aggregation concentration to each of these solutions, and add to room temperature. For 2 hours.
  • hedged erythrocytes were added to them, the agglutination of the hedged erythrocytes was examined, and the sugar concentration that inhibits the agglutinating activity of each lectin on erythrocytes was determined to determine the sugar-binding specificity of each lectin.
  • concentrations (gZml) required for various sugars to inhibit the agglutination reaction by 50% are shown for the fractions of lectins derived from Rhododendron rhinoceros, Yukiyuma cotney, Rhododendron rhinoceros rhinoceros and Akumasakirin rhinoceros. Shown along with 2.
  • Test Example 1 Measurement test of the blastogenic activity of mouse and human lymphocytes of lectins derived from Rhododendron spp.
  • lymphocyte fraction was obtained from the spleen according to a conventional method, and washed three times with RPMI 1640 medium containing 10% fetal calf serum.
  • lymphocyte cell suspension Zm 1 concentration was prepared.
  • EA0, EAl, EA2 and EA3 were found to have mouse lymphocyte blastogenesis activity.
  • the cultured cells in this culture solution were collected on a glass fiber filter (Whatman) using a cell harvester, dried, placed in a counting vial, and incorporated into lymphocytes using a liquid scintillation counter. The amount of thymidine was measured. .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A novel lectin characterized in that (a) it has a molecular weight of about 25 thousand as determined by gel filtration, (b) it has a molecular weight of about 29 thousand as determined by SDS electrophoresis, (c) it has an isoelectric point (pI) of from 4.5 to 5.7 as determined by isoelectric electrophoresis, (d) it does not have sugar chains, (e) it has an amino acid sequence of Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (wherein X represents Gln or Lys) at the N-terminus, (f) it has a specific agglutination activity against tripsinized rabbit erythrocytes, sheep erythrocytes and tripsinized sheep erythrocytes, and (g) it has a binding specificity for fetuin, asialofetuin, thyroglobulin and yeast mannan. It has physicochemical and biochemical properties different from those of known lectins. It is promising as a test reagent, an immunomodulator, and a specific adsorbent for separating and analyzing sugars because of the unique sugar-chain binding specificity thereof, as a rejection inhibitor for organ transplantation, an antitumor drug, and a preventive or remedy for autoimmune diseases and so forth because of the blastogenic activity thereof against lymphocytes, and as a growth factor for cell culture of lymphocytes and the like. According to the invention process, it can readily be separated from algae of the genus Eucheuma and purified in large amounts.

Description

明 細 書  Specification
新規レクチンおよびその製造方法  Novel lectin and method for producing the same
技術分野  Technical field
本発明は、 新規レクチンおよびその製造方法に関する。 特に海藻、 中でもキリ ンサイ属 (Euche議 a属または Kappaphycus属) の海藻に由来する新規レクチン及 びその製造方法に関する。  The present invention relates to a novel lectin and a method for producing the same. In particular, the present invention relates to a novel lectin derived from seaweed, in particular, a seaweed belonging to the genus Kirinsai (genus Euchea or Kappaphycus), and a method for producing the same.
背景技術  Background art
レクチンは動植物及び細菌等に見いだされる、 免疫学的産物ではない糖結合性 のタンパク質あるいは糖タンパク質の総称であり、 とりわけ、 陸上植物由来のレ クチンは赤血球凝集素として古くから知られている。 しかし、 近年においては、 陸上植物のみならず、 海藻からもいくつかのレクチンが見いだされており、 これ らのレクチンの中には、 赤血球を凝集させるだけでなく複合糖質を認識するもの などが発見され (堀ら, Botani ca Marina 29巻, 323-328 頁, 1986年など) 、 そ の生理的意義や特性が注目されるに至っている。  Lectin is a general term for sugar-binding proteins or glycoproteins that are not immunological products and are found in animals, plants, bacteria, etc. In particular, lectins derived from land plants have long been known as hemagglutinins. However, in recent years, several lectins have been found not only in land plants but also in seaweeds, and some of these lectins not only recognize erythrocytes but also recognize complex carbohydrates. It was discovered (Hori et al., Botani ca Marina Vol. 29, pp. 323-328, 1986), and its physiological significance and properties have attracted attention.
近年の研究の進展によって、 海藻のほとんどの種に何らかの赤血球凝集活性が 認められており (堀ら, Botani ca Marina 31巻, 133-138 頁, 1988年など) 、 そ の中のいくつかのものに関してはすでに精製され、 レクチンとしての性状が確認 されている (塩見ら, 日本水産学会誌 46 巻, 11号, 1369-1373 頁, 1980年等) c しかし、 海藻からレクチンを工業的なレベルで生産することを考えた場合、 収量 や精製方法、 工業的なスケールでの藻体量の確保など種々の問題がある。 Recent research has shown that some species of seaweed have some hemagglutinating activity (Hori et al., Botani ca Marina 31, pp. 133-138, 1988). Has already been purified and its properties as lectins have been confirmed (Shiomi et al., Journal of the Japanese Society of Fisheries Science, Vol. 46, No. 11, pp. 1369-1373, 1980, etc.) c However, lectins from seaweed at an industrial level When considering production, there are various problems such as yield, purification method, and securing of algal mass on an industrial scale.
現在多種類の動植物由来のレクチンが研究用試薬として販売されており、 その 他の実用面における用途開発も検討されているものの、 海藻レクチンに関しては、 ミル属由来のレクチンが 2種類試薬として販売されているのみである。  Currently, many kinds of lectins derived from animals and plants are sold as research reagents, and development of other practical applications is under consideration, but for seaweed lectins, lectins derived from the genus Mill are sold as two kinds of reagents. It is only.
一方、 従来キリンサイ属の海藻は、 カラギーナンの原藻や海藻サラダの原料と して利用されてきただけであり、 そこに含有される有効成分に関しては、 多糖類 の利用以外は未開発である。 従って、 かかる海藻資源の有効利用といった観点か らも、 これらの海藻よりレクチンのような高付加価値のある物質を生産するとい つた技術は大そう有用である。 発明の開示 On the other hand, the seaweed of the genus Kirinsai has only been used as a raw material for carrageenan algae and seaweed salad, and the active ingredients contained therein have not been developed except for the use of polysaccharides. Therefore, from the viewpoint of effective utilization of such seaweed resources, the technology of producing high value-added substances such as lectins from these seaweeds is very useful. Disclosure of the invention
かかる実情に鑑み、 本発明者らは多種多様の海藻を収集し、 海藻中のレクチン に関して鋭意研究を行った結果、 キリンサイ属の海藻中に新規なレクチンを見出 し、 その製造方法を確立することにより、 本発明を完成した。  In view of such circumstances, the present inventors have collected a wide variety of seaweeds and conducted intensive research on lectins in seaweeds.As a result, they have found novel lectins in seaweeds of the genus Kirinsai and established a method for their production. Thus, the present invention has been completed.
すなわち本発明は、  That is, the present invention
(a) ゲル濾過法による分子量が約 2 5, 0 0 0であり、  (a) the molecular weight by gel filtration is about 2,500,
(b) ドデシル硫酸ナトリウム (以下、 S D Sという) 電気泳動法による分子量が 約 2 9, 0 0 0であり、  (b) sodium dodecyl sulfate (hereinafter referred to as SDS) having a molecular weight of about 29,000 by electrophoresis,
(c) 等電点電気泳動法による等電点が p I 4 . 5〜p I 5 . 7の範囲にあり、 (c) the isoelectric point by isoelectric focusing is in the range of pI 4.5 to pI 5.7,
(d) 糖鎖を持たず、 (d) has no sugar chain,
(e) N末端領域のアミノ酸配列が、 Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (Xは Ginあるいは Lys)であり、  (e) the amino acid sequence of the N-terminal region is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (X is Gin or Lys),
(f) トリプシン処理ゥサギ赤血球、 ヒッジ赤血球及びトリプシン処理ヒッジ赤血 球に対して特異的な凝集活性を有し、  (f) Trypsin-treated ギ has specific agglutinating activity on heron erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes,
(g) フエチン、 ァシァ口フエチン、 チログロブリン及びイーストマンナンに対し て結合特異性を示すことを特徴とする新規レクチンを提供するものである。 また、 本発明は、 上記の新規レクチンの製造方法、 すなわち、 キリンサイ属に 属する海藻を原料とし、 緩衝液および溶媒—水混合液から選ばれる抽出溶媒で抽 出し、 その抽出液を溶媒沈殿及びゲル濾過、 好ましくはさらにイオン交換クロマ トグラフィ一の工程を経ることによって分離精製することを特徴とする新規レク チンの製造方法を提供するものである。  (g) The present invention provides a novel lectin characterized by exhibiting binding specificity to phytin, ash mouth phytin, thyroglobulin, and yeast mannan. Further, the present invention provides a method for producing the above-mentioned novel lectin, that is, using seaweed belonging to the genus Kirinsai as a raw material, extracting it with an extraction solvent selected from a buffer solution and a solvent-water mixture, and extracting the extract with solvent precipitation and gelation. An object of the present invention is to provide a method for producing a novel lectin, which is characterized in that the lectin is separated and purified by filtration, preferably further through one step of ion exchange chromatography.
まず、 本発明のレクチンについて説明する。 本発明の新規レクチンは、 上記の (a)〜(g)の特徴を有するものである。  First, the lectin of the present invention will be described. The novel lectin of the present invention has the above-mentioned characteristics (a) to (g).
以下、 これらの特徴に基づいて本発明のレクチンについて具体的に説明する。 (a), (b) 分子量  Hereinafter, the lectin of the present invention will be specifically described based on these characteristics. (a), (b) Molecular weight
本発明のレクチンは、 ゲル濾過法において約 2 5 , 0 0 0の分子量を示し、 ま た S D S電気泳動法において約 2 9 , 0 0 0の分子量を示すものである。  The lectin of the present invention exhibits a molecular weight of about 25,000 by gel filtration, and a molecular weight of about 29,000 by SDS electrophoresis.
本発明におけるゲル濾過法による分子量の決定は、 分子量測定用ゲル濾過カラ ムを用いた高速液体クロマトグラフィー 〔以下、 HPLCという、 条件;カラム: Superdex 75 HR (10x300 mm) 、 溶離液: 0.1 M NaCl含有 0.05 Mリン酸緩衝液 (pH7.2) 〕 により行うことができる。 より具体的には、 予め分子量既知の標準夕 ンパク質 〔アルドラ一ゼ (MW1 5 8, 0 0 0 ) 、 トランスフェリン (MW8 0, 0 0 0 ) 、 ゥシ血清アルブミン (MW6 8, 0 0 0 ) 、 オボアルブミン (MW4 3, 0 0 0 ) 、 カーボニックアンヒドラ一ゼ (MW32, O O iO S—ラクト グロプリン (MW1 8, 0 0 0 ) 、 ァプロチニン (MW 6, 5 0 0 ) 、 ビタミン B12 (MW 1, 3 5 5 ) 〕 を用いて作成した選択曲線から、 本発明のレクチンの 分子量を求めることができる。 The determination of the molecular weight by the gel filtration method in the present invention is performed by using a gel filtration color for molecular weight measurement. High-performance liquid chromatography using HPLC [hereinafter referred to as HPLC, conditions; column: Superdex 75 HR (10x300 mm), eluent: 0.05 M phosphate buffer (pH 7.2) containing 0.1 M NaCl] . More specifically, standard proteins with known molecular weights in advance (aldolase (MW158, 000), transferrin (MW800, 000), and serum albumin (MW68, 000)) , Ovalbumin (MW 43,000), carbonic anhydrase (MW32, OOiOS-lactoglobulin (MW18, 00), aprotinin (MW 6,500), vitamin B12 (MW 1, 355))] can be used to determine the molecular weight of the lectin of the present invention.
また、 ここでいう SDS電気泳動法とは、 ドデシル硫酸ナトリウムの存在下で 行うポリアクリルアミ ドゲル電気泳動法 (以下、 SDS— PAGEという) を意 味する。 本発明における SDS電気泳動法による分子量の決定は、 Laeimli の方 法 (Nature, 227巻, 680 頁, 1976年) による S D S— P A G Eに準じて行うこ とができる。 具体的には、 本発明のレクチンを SDS (0. 5 %) および 2—メ ルカプトエタノール (0. 5%) の存在下で 1 0 0°C、 3分間加熱処理した後、 SDS (0. 1 存在下、 1 , 0mmの 5〜2 0%濃度勾配ポリアクリルアミ ドスラブゲルを用いて電気泳動を行い、 次いで移動したレクチン試料の所在を、 同時に泳動した分子量既知の標準タンパク質 〔例えばゥシ血清アルブミン (MW 6 6, 0 0 0 ) 、 卵白アルブミン (MW 4 5, 0 0 0 ) 、 ゥサギ筋肉由来のグリ セルアルデヒド一 3—フォスフェイトデヒドロゲナ一ゼ (MW 3 6, 0 0 0 ) 、 牛赤血球由来のカーボニックアンヒドラーゼ (MW2 9, 0 0 0 ) 、 牛脬臓由来 のトリプシノーゲン (MW24, 0 0 0 ) 、 大豆由来のトリブシインヒビター (MW2 0, 1 0 0 ) 、 牛乳由来のひ—ラクトグロブリン (MW 1 4, 20 0 ) ) とともに色素等で染色することにより検出し、 分子量を決定することができる。 これらの分子量測定の結果から、 本発明のレクチンは上述のゲル濾過法で分子 量約 25, 0 0 0を示し、 かつ上述の SDS電気泳動法で分子量約 2 9, 0 0 0 を示す単量体であると思われる。  The term “SDS electrophoresis” as used herein means polyacrylamide gel electrophoresis (hereinafter referred to as SDS-PAGE) performed in the presence of sodium dodecyl sulfate. The determination of the molecular weight by the SDS electrophoresis in the present invention can be carried out according to the SDS-PAGE by Laeimli's method (Nature, 227, 680, 1976). Specifically, the lectin of the present invention was subjected to heat treatment at 100 ° C. for 3 minutes in the presence of SDS (0.5%) and 2-mercaptoethanol (0.5%), followed by SDS (0% In the presence of 1, electrophoresis was performed using a 10-mm 5% to 20% gradient polyacrylamide slab gel, and then the location of the transferred lectin sample was simultaneously analyzed with a standard protein of known molecular weight (e.g. Albumin (MW 66,000), ovalbumin (MW 45,000), glyceraldehyde-13-phosphate dehydrogenase (MW36,000) from cow heron muscle, cow Erythrocyte-derived carbonic anhydrase (MW290,000), bovine kidney trypsinogen (MW24,000), soybean-derived trypsin inhibitor (MW200,100), milk-derived milk —Detection by staining with lactoglobulin (MW 14,200)) And the molecular weight can be determined. From the results of these molecular weight measurements, the lectin of the present invention showed a molecular weight of about 25,000 by the above-mentioned gel filtration method, and a monomer having a molecular weight of about 29,000 by the above-mentioned SDS electrophoresis method. It seems to be the body.
(c) 等電点 本発明のレクチンは、 その等電点がポリアクリルァミ ドゲル等電点電気泳動法 にて測定される場合に、 P I 4. 5〜p I 5. 7の範囲にあるものである。 好ま しくは、 当該ポリアクリルアミ ドゲル等電点電気泳動法にて p 1 4. 75、 p I 4. 95、 p I 5. 05、 p I 5. 20及び p I 5. 50から選ばれる少なくと も一の等電点を示すものが挙げられる。 (c) Isoelectric point The lectin of the present invention has a PI of 4.5 to 5.7 when its isoelectric point is measured by polyacrylamide gel isoelectric focusing. Preferably, at least one selected from p1 4.75, pI4.95, pI5.05, pI5.20 and pI5.50 in the polyacrylamide gel isoelectric focusing method is used. Both of them have the same isoelectric point.
本発明におけるポリアクリルァミ ドゲル等電点電気泳動法による等電点の決定 は、 常法に従い、 両性担体として 2%の Amp h o l i n e (pH4〜6. 5) を用い、 7%のポリアクリルアミ ドゲル中で 460 V定電圧にて 20時間泳動す ることによって行うことができる。  Determination of isoelectric point by polyacrylamide gel isoelectric focusing in the present invention is carried out according to a conventional method, using 2% Ampholine (pH 4 to 6.5) as an amphoteric carrier and using a 7% polyacrylamide gel. It can be performed by running at 460 V constant voltage for 20 hours.
(d) 糖鎖の有無  (d) Sugar chain presence
本発明のレクチンは、 少なくとも測定標準試料としてグルコースを用いたフエ ノール硫酸法 CDubois.M., Gilles.K. A., Hamilton, J. K., Rebers.P. A. and Smith, F. (1956), Anal.Chem. 28, 357 〕 による測定で、 糖含量が実験誤差内で 0 %を示すものであり、 このことから糖鎖を有しないものであると判断される。 なお、 糖含量は以下の式にて求めることができる。  The lectin of the present invention is obtained by a phenol-sulfuric acid method using glucose as a measurement standard sample at least CDubois.M., Gilles.KA, Hamilton, JK, Rebers.PA and Smith, F. (1956), Anal.Chem. 28, 357] shows that the sugar content is 0% within the experimental error, and from this it is determined that the sugar chain is not present. The sugar content can be determined by the following equation.
{糖量/ / (タンパク質量 +糖量) } X 1 0 0 =糖含量 (%)  {Sugar content // (protein content + sugar content)} X 100 = sugar content (%)
また、 タンパク質量の測定には何ら制限はなく、 既知のいずれの方法をも用い ることができる。  There is no limitation on the measurement of the amount of protein, and any known method can be used.
(e) N末端領域のァミノ酸配列  (e) Amino acid sequence in N-terminal region
本発明のレクチンは、 N末端領域に Gly-Arg-Tyr-Thr-Val-Gln-Asn-Gln-Trp-Gly または Gly-Arg-Tyr-Thr- Val-Lys-Asn-Gln-Trp-Gly からなるアミノ酸配列を有す るタンパク質である。  The lectin of the present invention has a Gly-Arg-Tyr-Thr-Val-Gln-Asn-Gln-Trp-Gly or Gly-Arg-Tyr-Thr-Val-Lys-Asn-Gln-Trp-Gly in the N-terminal region. It is a protein having the following amino acid sequence:
アミノ酸配列の分析は、 例えば Applied Biosystems 477A PTH アナライザ一等 のァミノ酸分析機器を用いて行うことができる。  The amino acid sequence can be analyzed using an amino acid analyzer such as Applied Biosystems 477A PTH Analyzer.
すなわち、 本発明に包含されるレクチンは、 N末端領域の 1 0アミノ酸残基か らなるァミノ酸配列が、 N末端側から 6番目のァミノ酸残基がグルタミンかリジ ンであるかを除いては、 共通したアミノ酸配列を有することを特徵とする。 さら に、 N末端領域のアミノ酸配列の特徴に加えて、 本発明に包含されるレクチンは S D S電気泳動法またはゲル濾過法による分子量がそれぞれ同一であり、 かつ等 電点が p i 4 . 5〜p I 5 . 7の範囲で異なることから、 そのアミノ酸配列の一 部のアミノ酸残基 (少なくとも N末端側から 6番目のアミノ酸残基) が互いに異 なるものであると考えられる。 That is, the lectin included in the present invention has an amino acid sequence consisting of 10 amino acid residues in the N-terminal region, except that the sixth amino acid residue from the N-terminal side is glutamine or lysine. Are characterized by having a common amino acid sequence. Furthermore, in addition to the features of the amino acid sequence of the N-terminal region, the lectins included in the present invention Since the molecular weights obtained by SDS electrophoresis or gel filtration are the same and their isoelectric points differ from pi 4.5 to pI 5.7, some amino acid residues (at least (The sixth amino acid residue from the N-terminal side) are considered to be different from each other.
(f) 赤血球に対する凝集活性  (f) Agglutinating activity on erythrocytes
本発明のレクチンは、 ヒッジ赤血球、 トリプシン処理ゥサギ赤血球及びトリプ シン処理ヒッジ赤血球を特異的に凝集させるという特徴を有し、 その一方、 ゥサ ギ赤血球、 ゥマ赤血球、 ガチョウ赤血球、 トリプシン処理ゥマ赤血球およびトリ プシン処理ガチョウ赤血球のいずれに対しては凝集活性を有しないものである。 なお、 これらの赤血球に対する凝集活性は連続 2倍希釈法 〔B0TANICA MAR INA, 第 31巻、 第 133- 138 頁、 (1988)〕 を用いて測定して求めることができる。  The lectin of the present invention has a feature of specifically agglutinating ovine erythrocytes, trypsin-treated ギ egret erythrocytes and trypsin-treated whiskery erythrocytes, and, on the other hand, ego erythrocytes, ゥ red erythrocytes, goose erythrocytes, and trypsin-treated ゥ red blood cells. It has no agglutinating activity on either erythrocytes or trypsin-treated goose erythrocytes. The agglutinating activity on these erythrocytes can be determined by measuring using a serial two-fold dilution method [B0TANICA MAR INA, Vol. 31, pp. 133-138, (1988)].
(g) 糖結合特異性  (g) Sugar bond specificity
本発明のレクチンは、 単糖、 オリゴ糖に対しては特異的な結合を示さず、 ァシ ァロフエチン、 フエチン、 チログロブリン及びイーストマンナンに対して結合特 異性を有し、 また α 1一ァシッドグリコプロティンに対しても弱い結合特異性を 有するものである。 中でもチログロブリンおよびィ一ストマンナンに対しては、 特に強い結合特異性を有している。 即ち、 これらのチログロブリン、 イーストマ ンナンは、 糖タンパク質の中でも高マンノースタイプの糖鎖に富むものであるご とから、 本発明のレクチンは、 糖タンパク質中の Ν—グリコシド型糖鎖を認識し、 特にその中でも高マンノ一ス型を強く認識することが理解される。  The lectin of the present invention does not show specific binding to monosaccharides and oligosaccharides, has binding specificity to asialophetin, phytin, thyroglobulin, and yeast mannan, and has an α1-acid It also has weak binding specificity for glycoproteins. Among them, thyroglobulin and distmannan have particularly strong binding specificities. That is, since thyroglobulin and yeast mannan are rich in high mannose type sugar chains among glycoproteins, the lectin of the present invention recognizes Ν-glycoside type sugar chains in glycoproteins, and In particular, it is understood that the high Mannos type is strongly recognized.
なお、 レクチンの糖結合特異性は、 当該レクチンが特異的に凝集させることが できる特定の赤血球、 例えばヒッジ赤血球、 トリプシン処理ゥサギ赤血球または トリブシン処理ヒッジ赤血球を用い、 その赤血球の凝集反応を阻止しうる糖及び 配糖体を調べることにより確認することができる。  In addition, the sugar-binding specificity of the lectin can prevent the agglutination of the erythrocytes by using a specific erythrocyte which can specifically agglutinate the lectin, for example, a sheep erythrocyte, a trypsin-treated heron erythrocyte or a tribcine-treated shed erythrocyte. It can be confirmed by examining sugars and glycosides.
さらにまた、 本発明のレクチンは、 マウスやヒトのリンパ球に対して、 幼若化 活性を有することが確認されている (試験例 1参照) 。 なお、 レクチンのリンパ 球幼若化作用の測定は、 簡便でかつ客観性ある結果が得られることから、 培養し たマウスリンパ球またはヒトリンパ球に本発明のレクチンを加え、 細胞への3 Η- チミジン取り込みを放射能測定により M定する方法が好適に用いられる。 Furthermore, it has been confirmed that the lectin of the present invention has blastogenic activity on mouse and human lymphocytes (see Test Example 1). The measurement of lymphocyte transformation activity of the lectins since the simple and certain objective results, the lectin of the present invention was added to mouse lymphocytes or human lymphocytes were cultured, into cells 3 .eta. A method of determining thymidine incorporation by radioactivity measurement is preferably used.
かかる作用を有する本発明のレクチンは、 臨床的には細胞性免疫の生体外 (in vi tro)での検出ならびに評価などに役立つと言える。  It can be said that the lectin of the present invention having such an effect is clinically useful for in vitro detection and evaluation of cell-mediated immunity.
本発明のレクチンは、 以上の特徴を有するものであれば、 その由来等に特に制 限されることはないが、 好ましくは海藻、 とりわけキリンサイ属 (Eucheuma属ま たは Kappaphycus 属) に属する海藻から分離精製、 取得されるものである。  The lectin of the present invention is not particularly limited in its origin, etc., as long as it has the above characteristics, but is preferably a marine algae, especially a marine genus belonging to the genus Kirinsai (genus Eucheuma or Kappaphycus). It is obtained by separation and purification.
本発明のレクチンの由来となり得る海藻としては、 好適には日本及び世界各地 に成育するキリンサイ属 (Eucheuma属または Kappaphycus 属) の海藻が挙げられ る。  The seaweed that can be a source of the lectin of the present invention preferably includes seaweeds of the genus Kirinsai (genus Eucheuma or Kappaphycus) that grow in Japan and all over the world.
ところで、 従来の分類体系では紅藻キリンサイ属 (学名 : Eucheuma属) として いた海藻を、 近年 Euche画 a属と Kappaphycus 属に分離して記載している文献  By the way, in recent years, seaweed, which had been classified as the red alga Kirinsai genus (scientific name: Eucheuma genus), has recently been separated into Euche genus a and Kappaphycus genus.
(TAXONOMY OF ECONOMIC SEAWEEDS, 2巻, 157-219 頁, 1988年) が見られるが、 本発明におけるキリンサイ属とは、 Euche議 a属と Kappaphycus 属の二つの属をま とめたものを意味する。 また本明細書において、 各属名を区別して記載するとき、 適宜、 属名 : Eucheun^属を E.、 属名: Kappaphycus を K.と略記する.。  (TAXONOMY OF ECONOMIC SEAWEEDS, Vol. 2, pp. 157-219, 1988). In the present invention, the genus Kirinsai refers to a genus of the genus Euche a and the genus Kappaphycus. Further, in the present specification, when each genus name is distinguished and described, the genus name is abbreviated to E. for the genus Eucheun ^ and the genus name is K. for Kappaphycus.
本発明で用いられるキリンサイ属に属する海藻としては、 例えばトゲキリンサ ィ (E. serra)、 ュ一キユウマ コッ トニ一 cottoni i) 、 カタメンキリン サイ gelat inae)、 アマクサキリンサイ amakusaensis) 、 ^  Examples of seaweeds belonging to the genus Kirinsai used in the present invention include, for example, togekirinsai (E. serra), euphorma kottonii cottoni i), katamenkirin rhinocerat gelat inae), amasakirinsai amakusaensis), ^
dent iculatunu E. muri catum、 E. cupresoideum、 E. spinosunu E. arnoldi i- E. alvarezi i 、 E. striatum等の Eucheum属、 および procrusteanum、 Eucheum genus such as dent iculatunu E. muri catum, E. cupresoideum, E. spinosunu E. arnoldi i- E. alvarezi i, E. striatum, and procrusteanum,
K. cottoni i、 K. striatum^ K. alvarezi i 、 K. arnoldi i等の Kappaphycus属 に属する海藻が挙げられる。 好ましくはトゲキリンサイ serra), ユーキュ ゥマ コッ トニ一 cottoni i) 、 カタメンキリンサイ (E. gelat inae)およ びアマクサキリンサイ amakusaensis) である。 Seaweed belonging to the genus Kappaphycus, such as K. cottoni i, K. striatum ^ K. alvarezi i, and K. arnoldi i. Preferable ones are P. serra), E. plumeria cottoni i), E. gelat inae and A. makusaensis.
なお、 従来から、 ^ cottoni iと呼ばれていたカラギーナン製造用原藻は、 近 年 Euche醒属より分離して Kappaphycus procrusteanum と呼ぶことを提案して いる文献(SEAWEED CULTAVATION AND MARINE RANCHING, 75-88 頁, 1993年) もあ るが、 本発明ではユーキユウマ コッ トニ一 (E. cottoni i) と呼ぶことにする。 本発明のレクチンは、 これらの海藻から、 公知の抽出方法、 分離方法および精 製方法等を適宜組み合わせて行うことにより単離取得することができ、 その代表 的な製造法について、 以下詳細に説明する。 The original algae for carrageenan production, which was conventionally called ^ cottoni i, has recently been separated from Euche genus and proposed to be called Kappaphycus procrusteanum (SEAWEED CULTAVATION AND MARINE RANCHING, 75-88). P. 1993), but in the present invention, it will be referred to as E. cottonii. The lectin of the present invention can be isolated and obtained from these seaweeds by appropriately combining known extraction methods, separation methods, purification methods, and the like. Representative production methods are described in detail below. I do.
本発明のレクチンの製造方法は、 海藻、 とりわけキリンサイ属に属する海藻を 原料とし、 緩衝液および溶媒一水混合液から選ばれる抽出溶媒で抽出し、 その抽 出液を溶媒沈殿およびゲル濾過によつて分離精製することを特徵とする方法であ り、 さらに必要によりイオン交換クロマトグラフィーを行ってもよい。  The method for producing a lectin of the present invention comprises extracting seaweed, particularly seaweed belonging to the genus Kirinsai, with an extraction solvent selected from a buffer solution and a solvent-water mixture, and subjecting the extracted solution to solvent precipitation and gel filtration. This method is characterized in that it is separated and purified, and if necessary, ion exchange chromatography may be performed.
当該方法に使用される海藻としては、 好適には前述のキリンサイ属 (Eucheuma 属または Kappaphycus 属) に属する海藻が挙げられ、 さらに当該キリンサイ属に 属する海藻としては、 前述のトゲキリンサイ serra)、 ュ一キユウマ コッ トニー cottoni i) 、 カタメンキリンサイ (E. gelatinae)、 アマクサキリ ンサイ (E. amakusaensis) 、 E. dent iculatum^ E. rauricatum、 E.  The seaweeds used in the method preferably include seaweeds belonging to the genus Kirinsai (genus Eucheuma or Kappaphycus). E. gelatinae, E. amakusaensis, E. dent iculatum ^ E. rauricatum, E.
cupresoideunu E. spinosum、 E. arnoldi i s E. alvarezi i 、 E. striatum等 の Eucheuma属ぉよび^ _ procrusteanum、 K. cottoni i K. striatum. K, alvarezi i 、 L_ arnoldi i等の Kappaphycus 属に属する海藻が挙げられる。 レク チンの含有量や入手のし易さ等から判断し、 好ましくはトゲキリンサイ . serra). ュ一キユウマ コッ トニ一 cottoni i) 、 カタメンキリンサイ(E. gelatinae)- アマクサキリンサイ (E. amakusaensis) 、 E. denticulat圆、 E. spinosunu E. alvarezi i 、 K. procrusteanum および cottoni iゝ alvarezi i であ り、 特に好ましいのは、 トゲキリンサイ (E. serra), ュ一キユウマ コッ トニー cottoni i) 、 カタメンキリンサイ (E. gelat inae)およびアマクサキリンサ ィ (E. amakusaensis) でめる。 seaweed belonging to the genus Kappaphycus such as cupresoideunu E. spinosum, E. arnoldi is E. alvarezi i, E. striatum, etc. Is mentioned. Judging from the content of lectin and the availability of lectin, etc., it is preferable to use serra).. ユ ユ cotton cotton cotton, カ タ カ タ E E E cotton, E. denticulat 圆, E. spinosunu E. alvarezii, K. procrusteanum and cottoni i ゝ alvarezii, and particularly preferred are E. serra, E. serra, C. cottonii and (E. gelat inae) and E. amakusaensis.
レクチンの製造にあたり、 まず、 これらの海藻を採取し、 海水にて良く洗浄し た後、 凍結乾燥を行い、 その後粉砕して海藻粉末とするのが好ましい。  In the production of lectin, it is preferable to first collect these seaweeds, wash them well with seawater, freeze-dry them, and then pulverize them into seaweed powder.
次いで、 得られた海藻粉末を適当な抽出溶媒を用いて抽出する。  Next, the obtained seaweed powder is extracted using a suitable extraction solvent.
抽出溶媒としては、 各種の緩衝液、 水と混合しうる各種の有機溶媒或いは有機 溶媒と水の混合溶液等いずれも使用することができる。 好ましくは、 緩衝液ある いは有機溶媒と水との混合溶液が挙げられる。 緩衝液としては、 特に制限されることなく公知の各種の緩衝液が挙げられるが、 好適には p H 3〜 1 0の範囲に緩衝能を有するものが挙げられる。 As the extraction solvent, any of various buffers, various organic solvents that can be mixed with water, or a mixed solution of an organic solvent and water can be used. Preferably, a mixed solution of a buffer or an organic solvent and water is used. Examples of the buffer include, but are not particularly limited to, various known buffers, and a buffer having a buffering ability in the pH range of 3 to 10 is preferable.
また、 有機溶媒としては、 アセトン、 メタノール、 エタノール或いはイソプロ パノールが好ましい。 その中でもとりわけ 1 0 %ないし 4 0 %迄のエタノール一 水混合液を用いるのが好適である。  As the organic solvent, acetone, methanol, ethanol or isopropanol is preferable. Among them, it is particularly preferable to use a mixed solution of ethanol and water of 10% to 40%.
具体的には、 例えば海藻粉末に 2 5 %のエタノール水溶液を加え、 必要に応じ 低温に保ちながら抽出し、 海藻抽出液を得る。 次いで、 該海藻抽出液を濾過、 或 いは遠心分離することによつて上清と抽出残査とに分離し、 上清を本発明のレク チンを含む抽出液として回収する ( 1次抽出液) 。 また、 抽出残査に再び 2 5 % のェ夕ノール水溶液を加えて、 2次抽出を行って本発明のレクチンを含む抽出液 として回収してもよい (2次抽出液) 。  Specifically, for example, a 25% ethanol aqueous solution is added to seaweed powder, and extraction is performed while maintaining the temperature as low as necessary, to obtain a seaweed extract. Next, the seaweed extract is separated into a supernatant and an extraction residue by filtration or centrifugation, and the supernatant is recovered as an extract containing the lectin of the present invention (primary extract) ). Alternatively, a 25% aqueous solution of ethanol may be added again to the extraction residue to perform a second extraction and collect as an extract containing the lectin of the present invention (secondary extract).
さらに、 上記の抽出液に対して、 溶媒沈澱操作、 例えば硫酸アンモニゥ厶によ る塩析 (以下、 硫安塩析という) または有機溶媒による沈殿等を行うことにより 本発明のレクチンを含む夕ンパク質を回収することできる。  Further, the extract containing the lectin of the present invention is subjected to a solvent precipitation operation, for example, salting out with ammonium sulfate (hereinafter referred to as ammonium sulfate salting out) or precipitation with an organic solvent. Can be recovered.
硫安塩析は、 常法により行うことができ、 通常 0〜8 0 %飽和硫安、 好ましく は 2 0〜8 0 %飽和硫安により沈澱した画分を回収することにより行われる。 また、 有機溶媒による沈殿は、 先の抽出操作で用いられる抽出溶媒の種類に係わ らず、 任意の水溶性有機溶媒を用いて常法により行うことができる。 好ましい有 機溶媒としてはアセトン、 メタノール、 エタノール或いはイソプロパノール等が 挙げられるが、 とりわけエタノールが好適である。 例えば、 エタノール一水混合 液で抽出した場合、 冷エタノールを適量加えてエタノールの最終濃度が 7 0 %以 上となるようにすると、 本発明のレクチンを含むタンパク質は沈殿となって析出 してくる。  Ammonium sulfate salting out can be carried out by a conventional method, and is usually carried out by collecting a fraction precipitated with 0 to 80% saturated ammonium sulfate, preferably 20 to 80% saturated ammonium sulfate. Precipitation with an organic solvent can be carried out by an ordinary method using any water-soluble organic solvent, regardless of the type of extraction solvent used in the previous extraction operation. Preferred organic solvents include acetone, methanol, ethanol, isopropanol and the like, with ethanol being particularly preferred. For example, when extracting with an ethanol-water mixture, if the final concentration of ethanol is adjusted to 70% or more by adding an appropriate amount of cold ethanol, the protein containing the lectin of the present invention precipitates as a precipitate. .
これらの方法によって得られる沈殿画分を常法によって回収し、 緩衝液 (P H 6〜8 ) に懸濁し、 同緩衝液に対して透析して溶媒を除去することにより本発明 のレクチンの粗製液を得ることができる。  The precipitate fraction obtained by these methods is collected by a conventional method, suspended in a buffer solution (PH 6 to 8), dialyzed against the buffer solution, and the solvent is removed to obtain a crude solution of the lectin of the present invention. Can be obtained.
次いで、 溶媒除去を行ったレクチンの粗製液をゲル濾過に供することにより、 本発明のレクチンを容易に単離精製することができる。 ゲル濾過で用いる充塡剤は、 排除限界分子量が 1 0 0 , 0 0 0以下の各種製品 を使用するのが好ましい。 好ましくは、 かかる充塡剤を充塡したカラムを用いる ゲル濾過カラムクロマトグラフィーである。 なお、 溶離液としては、 レクチンの 物理的および生化学的性質に影響を与えないものであれば特に限定されず、 例え ば 0〜 1 M程度の塩を含有する 0. 5〜 1 0 O mM程度のリン酸緩衝液 (p H 6〜 9 ) が挙げられる。 Next, the lectin of the present invention can be easily isolated and purified by subjecting the crude lectin solution from which the solvent has been removed to gel filtration. As the filler used in the gel filtration, it is preferable to use various products having an exclusion limit molecular weight of 100,000 or less. Preferred is gel filtration column chromatography using a column filled with such a packing material. The eluent is not particularly limited as long as it does not affect the physical and biochemical properties of the lectin.For example, the eluent contains a salt of about 0 to 1 M. Phosphate buffer (pH 6 to 9).
具体的には、 レクチンの粗製液をゲル濾過用カラムに付した後、 溶離液を供し - ながら、 該カラム通過液を一定の間隔で分取し、 ヒッジ赤血球等の本発明のレク チンが凝集活性を示す赤血球を用いて各画分の赤血球に対する凝集活性をモニタ 一することによって行うことができる。 なお、 赤血球に対する凝集活性は連続 2 倍希釈法 CBOTANICA MARINA,第 31巻、 第 133 - 138 頁、 (1988)〕 により求めること ができる。  Specifically, a crude lectin solution is applied to a column for gel filtration, and then the eluate is supplied while the eluent is supplied. It can be carried out by monitoring the agglutinating activity of each fraction on erythrocytes using erythrocytes showing activity. The agglutinating activity on erythrocytes can be determined by the serial two-fold dilution method CBOTANICA MARINA, Vol. 31, pp. 133-138, (1988)].
その結果、 本発明のレクチン画分として、 紫外線吸収 (2 8 0 n m) の最も大 きなピークと赤血球に対する凝集活性のピークが一致する画分を取得することが できる。 なお、 前述の 1次抽出液、 2次抽出液の両者から共に当該レクチン画分 が取得できる。  As a result, it is possible to obtain, as the lectin fraction of the present invention, a fraction in which the maximum peak of ultraviolet absorption (280 nm) coincides with the peak of agglutination activity for erythrocytes. The lectin fraction can be obtained from both the primary extract and the secondary extract described above.
以上の操作により、 S D S電気泳動においてシングルバンドとして確認され得 る、 9 0数%以上の純度にまで精製されたレクチンを製造取得することができる。 また、 原料として用いる海藻の種類によっては、 かかる操作により 9 9 %以上の 純度にまで精製されたレクチンを製造取得することができる。  By the above operation, a lectin purified to 90% or more purity, which can be confirmed as a single band in SDS electrophoresis, can be obtained. In addition, depending on the type of seaweed used as a raw material, a lectin purified to a purity of 99% or more can be produced and obtained by such an operation.
以上の方法により製造されるレクチンは、 出発原料となる海藻の種類に係わら ず、 以下の特徴を有するものである。  The lectin produced by the above method has the following characteristics irrespective of the type of seaweed used as a starting material.
(a) ゲル濾過法による分子量が約 2 5 , 0 0 0であり、  (a) the molecular weight by gel filtration is about 25,000,
(b) S D S電気泳動法による分子量が約 2 9 , 0 0 0であり、  (b) the molecular weight by SDS electrophoresis is about 29,000,
(c) 等電点電気泳動法にて、 p I 4 . 5〜p I 5 . 7の範囲にある 1または 2以上 の等電点を示し、  (c) by isoelectric focusing, showing one or more isoelectric points in the range of pI4.5 to pI5.7,
(d) 糖鎖を持たず、  (d) has no sugar chain,
(e) N末端領域のアミノ酸配列が、 Gly-Arg- Tyr-Thr-Val-X-Asn-Gln- Trp-Gly (Xは Ginあるいは Lys)であり、 (E) the amino acid sequence of the N-terminal region is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (X is Gin or Lys)
(f) トリプシン処理ゥサギ赤血球、 ヒッジ赤血球及びトリプシン処理ヒッジ赤血 球に対して特異的な凝集活性を有し、  (f) Trypsin-treated ギ has specific agglutinating activity on heron erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes,
(g) フエチン、 ァシァ口フエチン、 チログロブリン及びイーストマンナンに対し て結合特異性を示す。  (g) Shows binding specificity for phytin, ash mouth phytin, thyroglobulin, and yeast mannan.
また、 上記ゲル濾過法により得られるレクチン画分は、 必要に応じてさらにィ オン交換クロマトグラフィー、 好適には陰イオン交換クロマトグラフィーに供す ることができる。 具体的には、 ゲル濾過後のレクチン画分をジェチルアミノエチ ル (DEAE) 基等の弱陰イオン交換基を有する担体を用いた陰イオン交換クロ マトグラフィ一に供し、 好ましくは塩によるリニアグラジェント溶出法で分画す る。 かかる方法により、 ゲル濾過法により得られるレクチン画分は、 該画分に含 有されるレクチンに応じて、 さらに等電点のみがわずかに異なる複数の画分に分 画することができる。 すなわち、 ゲル濾過法により得られるレクチン画分に複数 の等電点を有するレクチンが含まれている場合、 当該イオン交換クロマトグラフ ィ一により各等電点を有する個々のレクチンに単離精製することができる。  In addition, the lectin fraction obtained by the above gel filtration method can be further subjected to ion exchange chromatography, preferably anion exchange chromatography, if necessary. Specifically, the lectin fraction after gel filtration is subjected to anion-exchange chromatography using a carrier having a weak anion-exchange group such as getylaminoethyl (DEAE) group. Fractionate by the gentle elution method. By such a method, the lectin fraction obtained by the gel filtration method can be further fractionated into a plurality of fractions having only slightly different isoelectric points according to the lectin contained in the fraction. That is, when the lectin fraction obtained by the gel filtration method contains a lectin having a plurality of isoelectric points, it should be isolated and purified into individual lectins having respective isoelectric points by the ion exchange chromatography. Can be.
かかる方法により製造され得るレクチンは、 分子量、 糖鎖の有無、 アミノ酸配 列、 赤血球凝集活性および糖結合特異性については、 ゲル濾過法により得られる レクチンの諸性質 〔(a), (b)及び (d) 〜(g) 〕 と同じであり、 かつ等電点電気泳 動法による等電点が P I 4. 5〜p I 5. 7の範囲にある一点を示すという特徴 を有するものである。  The lectin that can be produced by such a method is characterized in terms of molecular weight, presence or absence of sugar chains, amino acid sequence, hemagglutinating activity and sugar-binding specificity, by various properties of the lectin obtained by gel filtration ((a), (b) and (d) to (g)), and has the characteristic that the isoelectric point measured by the isoelectric point electrophoresis method indicates one point in the range of PI 4.5 to pI 5.7. .
なお、 ゲル濾過法で得られるレクチン画分に含まれるレクチンの数は、 原料と して用いられるキリンサイ属の種類によって異なり、 また含まれる各レクチンの の等電点もキリンサイ属の種類によって P I 4. 5から p i 5. 7の間でわずか に違いが見られる。 例えば、 トゲキリンサイを原料とする場合は、 等電点電気泳 動法にて、 p i 4. 75又は p i 4. 95の等電点を示すレクチンが、 ユーキュ ゥマ コッ トニーを原料とする場合は p I 5. 05または p i 5. 20の等電点 を示すレクチンが、 カタメンキリンサイまたはアマクサキリンサイを原料とする 場合は p i 4. 95、 p i 5. 20または p i 5. 50の等電点を示すレクチン が得られる。 The number of lectins contained in the lectin fraction obtained by the gel filtration method varies depending on the type of giraffe used as a raw material, and the isoelectric point of each lectin contained also varies depending on the type of giraffe. There is a slight difference between 5 and pi 5.7. For example, in the case of using Papaver rhinoceros as a raw material, a lectin exhibiting an isoelectric point of pi 4.75 or pi 4.95 by isoelectric focusing If the lectin with pI 5.05 or pi 5.20 is derived from the Japanese rhinoceros or linden, it will have pi 4.95, pi 5.20 or pi 5.50 Lectin Is obtained.
なお、 ゲル濾過法によって取得されるレクチン、 に陰イオン交換クロマトグ ラフィーによって取得されるレクチンおよびそれら各レクチンの混合物は、 それ ぞれマウスおよびヒトリンパ球に対して、 幼若化活性を有することが確認されて いる。  Lectins obtained by gel filtration, lectins obtained by anion-exchange chromatography, and mixtures of these lectins were confirmed to have blastogenic activity on mouse and human lymphocytes, respectively. It has been.
本発明のレクチンは、 従来のレクチンと物理化学的性質が異なり、 糖鎖べの結 合特異性などの生化学的性質も異なる新規レクチンである。 また従来公知のレク チンである P H A (phytohemagglut inin) 、 コンカナパリン A等と同様に、 その 独特な糖鎖結合特異性を利用して検査試薬、 免疫調節剤、 糖質の分離分析用特異 的吸着剤等の用途が考えられるほか、 その糖鎖への親和性を利用した他の様々な 方面への応用が期待される。  The lectin of the present invention is a novel lectin having different physicochemical properties from conventional lectins, and also different biochemical properties such as specificity of sugar chain binding. In addition, like the well-known lectins PHA (phytohemagglutinin), concanapalin A, etc., they utilize their unique sugar chain binding specificity to test reagents, immunomodulators, and specific adsorbents for separation and analysis of carbohydrates. In addition to its use, it is expected to be applied to various other fields using its affinity for sugar chains.
また、 リンパ球に由来する細胞、 その他有用物質を産生する細胞を大量培養する 際の増殖因子として培地に添加するという利用も期待される。  It is also expected to be used as a growth factor when mass-culturing cells derived from lymphocytes and other cells that produce useful substances.
さらに本発明のレクチンは、 リンパ球に対して幼若化活性を示すことから、 ヒ ト、 ゥシ、 ゥマ、 ィヌ、 マウス等の哺乳動物に対して、 例えば臓器や骨髄移植の 際の拒絶反応の抑制剤、 リンパ球活性化を介して抗腫瘍効果を奏しえる抗腫瘍剤、 もしくは関節リウマチ、 免疫不全等の自己免疫疾患等における予防または治療剤 として、 あるいは医学,薬学における試薬として用いることができる。  Furthermore, since the lectin of the present invention has a blastogenic activity on lymphocytes, it can be used in mammals such as humans, mice, dogs, dogs, and mice, for example, when transplanting organs or bone marrow. Used as an inhibitor of rejection, an antitumor agent capable of exerting an antitumor effect through lymphocyte activation, or as a preventive or therapeutic agent for autoimmune diseases such as rheumatoid arthritis, immunodeficiency, etc., or as a reagent in medicine or pharmaceuticals be able to.
本発明のレクチンは、 単一物もしくは等電点の異なる複数のものの混合物とし て、 医薬上許容される担体、 賦形剤、 希釈剤等と混合して散剤、 カプセル剤、 錠 剤、 軟膏等に製剤化して患者に投与することができる。 また、 自体既知の手段に て凍結乾燥製剤としてもよい。 更にまた、 同様に化粧品としての使用も可能であ る。 かかる目的のため、 本発明のレクチンは、 通常成人 1 日当たり、 0. 1〜 1 0 0 O m gの範囲で、 患者の疾患、 症状、 体重、 性別および年齢等を考慮して適宜 選択される量を 1 日 1回〜数回に分けて投与される。  The lectin of the present invention may be used alone, or as a mixture of a plurality of substances having different isoelectric points, mixed with a pharmaceutically acceptable carrier, excipient, diluent, etc., to give powders, capsules, tablets, ointments, etc. And administered to patients. Alternatively, a freeze-dried preparation may be prepared by a means known per se. Furthermore, it can also be used as cosmetics. For this purpose, the lectin of the present invention is used in an amount of 0.1 to 100 mg / day, which is appropriately selected in consideration of a patient's disease, symptoms, weight, sex, age, etc., usually per adult. Is administered once to several times a day.
さらに、 本発明の製造方法によれば、 かかる有用なレクチンを海藻、 とりわけ キリンサイ属に属する海藻より簡便な方法で分離精製して大量に取得することが 可能であり、 レクチンの工業的生産をもたらすことができる。 図面の簡単な説明 Furthermore, according to the production method of the present invention, such a useful lectin can be separated and purified from seaweeds, particularly seaweeds belonging to the genus Kirinsai, by a simpler method to obtain a large amount thereof, resulting in industrial production of lectins. be able to. BRIEF DESCRIPTION OF THE FIGURES
図 1は、 トゲキリンサイ由来のレクチン粗製液をゲル濾過クロマトグラフィー に付したクロマトグラムを示す。 図 2は、 トゲキリンサイ由来レクチン粗製液の ゲル濾過クロマトグラフィー後の活性画分 (レクチン ES 0) を DEAEイオン 交換クロマトグラフィーに付したクロマトグラムを示す。 図 3は、 ユーキユウマ コッ トニー由来レクチン粗製液のゲル濾過クロマトグラフィー後の活性画分 (レ クチン EC 0) を DEAEイオン交換クロマトグラフィーに付したクロマトグラ ムを示す。 図 4は、 カタメンキリンサイ由来レクチン粗製液のゲル濾過クロマト グラフィー後の活性画分 (レクチン EG 0) の DEAEイオン交換クロマトグラ フィ一に付したクロマトグラムを示す。 図 5は、 アマクサキリンサイ由来レクチ ン粗製液のゲル濾過クロマトグラフィー後の活性画分 (レクチン EA0) の DE AEイオン交換クロマトグラフィーに付したクロマトグラムを示す。 なお、 各図 中、 ——は吸光度 (280nm)、 ……は赤血球凝集活性の力価を意味する。  FIG. 1 shows a chromatogram obtained by subjecting a crude lectin solution derived from Rhododendron rhizome to gel filtration chromatography. FIG. 2 shows a chromatogram obtained by subjecting an active fraction (lectin ES 0) of a crude lectin solution derived from Pterodactylus to a DEAE ion exchange chromatography after gel filtration chromatography. FIG. 3 shows a chromatogram obtained by subjecting the active fraction (lectin EC0) of the crude lectin solution derived from Yukiyama Cotney after gel filtration chromatography to DEAE ion exchange chromatography. FIG. 4 shows a chromatogram of an active fraction (lectin EG0) obtained by gel filtration chromatography of a crude lectin solution derived from Rhinoceros oryzae, which was applied to DEAE ion exchange chromatography. FIG. 5 shows a chromatogram of an active fraction (lectin EA0) after gel filtration chromatography of a crude lectin solution derived from Acacia officinalis subjected to DE AE ion exchange chromatography. In each of the figures, “—” means absorbance (280 nm), and …… means the hemagglutination activity titer.
以下、 本発明をより詳細に説明するために実施例および試験例を挙げるが、 本 発明は、 これらによって限定されるものではない。  Hereinafter, examples and test examples will be described in order to explain the present invention in more detail, but the present invention is not limited by these.
実施例 1〜 4 Examples 1-4
トゲキリンサイ serra)由来のレクチン、 ユーキユウマ コッ トニー cottonii) 由来のレクチン、 力夕メンキリンサイ (Eucheuma gelatinae)由来の レクチンまたはアマクサキリンサイ amakusaensis) 由来のレクチンの分離 精製、 及びその物理化学的および生化学的試験等について説明する。  Separation and purification of lectins derived from P. serra), lectins derived from Yukiyuma cotney cottonii), lectins derived from Eucheuma gelatinae or lectins derived from Amakusaensis, and their physicochemical and biochemical tests. Will be described.
( 1 ) 藻体の調製  (1) Preparation of algal bodies
(1-1) 四国の太平洋沿岸に成育するトゲキリンサイを採取し、 海水にてよく 洗浄した後、 凍結乾燥を行い、 粉砕機にて粉砕し海藻粉末を得た。  (1-1) Spruce ginseng growing on the Pacific coast of Shikoku was collected, washed well with seawater, freeze-dried, and crushed with a crusher to obtain seaweed powder.
(1-2) 熱帯海域にてカラギーナン原藻として大量に養殖されているユーキュ ゥマ コッ トニ一を採取し、 海水にて良く洗浄した後、 凍結乾燥を行い、 粉砕機 にて粉砕し海藻粉末を得た。  (1-2) Eucoma cotonii, which is cultured in large quantities as carrageenan algae in tropical seas, is collected, washed well with seawater, freeze-dried, and pulverized with a pulverizer to obtain seaweed powder. I got
(1-3) 九州の太平洋沿岸に成育する力夕メンキリンサイを採取し、 海水にて よく洗浄した後、 凍結乾燥を行い、 粉砕機にて粉砕し海藻粉末を得た。 (1-4) 四国および九州に成育するアマクサキリンサイを採取し、 海水にてよ く洗浄した後、 凍結乾燥を行い、 粉砕機にて粉砕し海藻粉末を得た。 (1-3) Harvesting rhinoceros ginseng growing on the Pacific coast of Kyushu was collected, washed well with seawater, freeze-dried, and crushed with a crusher to obtain seaweed powder. (1-4) Amaranthus rhinoceros growing in Shikoku and Kyushu was collected, washed well with seawater, freeze-dried, and crushed with a crusher to obtain seaweed powder.
( 2 ) 藻体からのレクチンの抽出  (2) Extraction of lectin from algae
(2-1) 上記(1-1) のトゲキリンサイ海藻粉末 1 0 0 gに 2 0 %のエタノール 水溶液 1 0 0 0 m lを加え冷蔵庫中で一晩攪拌しながら抽出し、 海藻抽出液を得 た。 遠心分離によって上清と抽出残査を分離し、 上清を回収した。 抽出残査に再 び同量の 2 0 %ェタノール水溶液を加えて 2次抽出を行い、 同様にして上清を回 収した。 その結果、 8 4 0 m 1の 1次抽出液と 9 0 0 m lの 2次抽出液を得た。  (2-1) 100 g of a 20% aqueous ethanol solution was added to 100 g of the powdered seaweed rhinoceros algae of the above (1-1), and the mixture was extracted with stirring overnight in a refrigerator to obtain a seaweed extract. Was. The supernatant and the extraction residue were separated by centrifugation, and the supernatant was collected. The same amount of a 20% aqueous ethanol solution was again added to the extraction residue to perform secondary extraction, and the supernatant was recovered in the same manner. As a result, a primary extract of 840 ml and a secondary extract of 900 ml were obtained.
(2-2) 上記(1-2) のュ一キユウマ コッ トニー海藻粉末 1 0 0 gに 2 3 %の エタノール水溶液 1 0 0 0 m 1を加え冷蔵庫中で一晩攪拌しながら抽出し、 海藻 抽出液を得た。 遠心分離によって上清と抽出残査を分離し、 上清を回収した。 抽 出残査に再び同量の 2 3 %のエタノール水溶液を加えて 2次抽出を行い、 同様に して上清を回収した。 その結果、 8 3 O m 1の 1次抽出液と 8 9 5 m 1の 2次抽 出液を得た。  (2-2) To 100 g of the Eucalyptus cotonii seaweed powder of (1-2) above was added 100% of a 23% aqueous ethanol solution, and the mixture was extracted while stirring overnight in a refrigerator. An extract was obtained. The supernatant and the extraction residue were separated by centrifugation, and the supernatant was collected. The same amount of a 23% aqueous ethanol solution was again added to the extraction residue to perform secondary extraction, and the supernatant was recovered in the same manner. As a result, a primary extract of 83 Om1 and a secondary extract of 8995 m1 were obtained.
(2-3) 上記(1-3) のカタメンキリンサイ海藻粉末 1 0 0 gに 2 5 %のェタノ ール水溶液 1 0 0 0 m lを加え冷蔵庫中で一晩攪拌しながら抽出し、 海藻抽出液 を得た。 遠心分離によって上清と抽出残査を分離し、 上清を回収した。 抽出残查 に再び同量の 2 5 %のエタノール水溶液を加えて 2次抽出を行い、 同様にして上 清を回収した。 その結果、 8 4 O m 1の 1次抽出液と 8 9 0 m lの 2次抽出液を 得た。  (2-3) 100 ml of 25% aqueous ethanol solution was added to 100 g of the powdered seaweed rhinoceros algae of (1-3), and the mixture was extracted while stirring overnight in a refrigerator. I got The supernatant and the extraction residue were separated by centrifugation, and the supernatant was collected. The same amount of a 25% aqueous ethanol solution was again added to the extraction residue to perform secondary extraction, and the supernatant was recovered in the same manner. As a result, a primary extract of 84 Om1 and a secondary extract of 890 ml were obtained.
(2-4) 上記のアマクサキリンサイ海藻粉末 1 0 0 gに 2 5 %のエタノール水 溶液 1 0 0 0 m lを加え冷蔵庫中で一晩攪拌しながら抽出し、 海藻抽出液を得た。 遠心分離によって上清と抽出残査を分離し、 上清を回収した。 抽出残查に再び同 量の 2 5 %エタノール水溶液を加えて 2次抽出を行い、 同様にして上清を回収し た。 その結果、 8 4 5 m lの 1次抽出液と 8 9 0 m 1の 2次抽出液を得た。  (2-4) 100 ml of a 25% ethanol aqueous solution was added to 100 g of the above-mentioned seaweed powder, and extracted with stirring in a refrigerator overnight to obtain a seaweed extract. The supernatant and the extraction residue were separated by centrifugation, and the supernatant was collected. The same amount of a 25% aqueous ethanol solution was again added to the extraction residue to perform secondary extraction, and the supernatant was recovered in the same manner. As a result, 845 ml of the primary extract and 890 ml of the secondary extract were obtained.
(3) 抽出液からのレクチンの回収  (3) Recovery of lectin from extract
(3-1) 上記 (2-1) のトゲキリンサイ由来の抽出液からレクチンを回収するた めに、 該抽出液に冷エタノールを最終濃度 8 3 %となるように適量加え、 レクチ ンを含むタンパク質を沈殿として析出させた。 該沈殿物を遠心分離によって回収 し、 5 OmMのリン酸緩衝液 (pH 7. 2) に懸濁し、 同緩衝液に対して透析を 行ってエタノールを除去し、 レクチンの粗製液を得た。 (3-1) In order to recover lectin from the extract derived from Rhododendron rhinoceros described in (2-1) above, an appropriate amount of cold ethanol was added to the extract to a final concentration of 83%, and lectin was added. The protein containing the protein was precipitated as a precipitate. The precipitate was collected by centrifugation, suspended in 5 OmM phosphate buffer (pH 7.2), dialyzed against the buffer, and ethanol was removed to obtain a crude lectin solution.
(3-2) 上記(2-2) のュ一キユウマ コッ トニー由来の抽出液からレクチンを 回収するために、 該抽出液に冷エタノールを最終濃度 8 0%となるように適量加 え、 レクチンを含むタンパク質を沈殿として析出させた。 該沈殿物を遠心分離に よって回収し、 5 OmMのリン酸緩衝液 (pH 7. 2) に懸濁し、 同緩衝液に対 して透析を行ってェタノ一ルを除去し、 レクチンの粗製液を得た。  (3-2) In order to recover lectin from the extract derived from C. elegans in (2-2) above, an appropriate amount of cold ethanol was added to the extract to a final concentration of 80%. Was precipitated as a precipitate. The precipitate was recovered by centrifugation, suspended in 5 OmM phosphate buffer (pH 7.2), dialyzed against the same buffer to remove ethanol, and crude lectin solution was recovered. I got
(3-3) 上記 (2-3) のカタメンキリンサイ由来の抽出液からレクチンを回収す るために、 該抽出液に冷エタノールを最終濃度 8 1 %となるように適量加え、 レ クチンを含む夕ンパク質を沈殿として析出させた。 該沈殿物を遠心分離によって 回収し、 5 OmMのリン酸緩衝液 (pH 7. 2) に懸濁し、 同緩衝液に対して透 析を行ってエタノールを除去し、 レクチンの粗製液を得た。  (3-3) In order to recover lectin from the extract derived from P. chinensis in (2-3) above, an appropriate amount of cold ethanol is added to the extract to a final concentration of 81%, and the lectin is contained. Evening protein was precipitated as a precipitate. The precipitate was collected by centrifugation, suspended in 5 OmM phosphate buffer (pH 7.2), and the buffer was subjected to precipitation to remove ethanol to obtain a crude lectin solution. .
(3-4) 上記(2-4) のアマクサキリンサイ由来の抽出液からレクチンを回収す るために、 冷エタノールを最終濃度 8 1 %となるように適量加え、 レクチンを含 むタンパク質を沈殿として析出させた。 該沈殿物を遠心分離によって回収し、 50 mMのリン酸緩衝液 (pH 7. 2) に懸濁し、 同緩衝液に対して透析を行ってェ 夕ノールを除去し、 レクチンの粗製液を得た。  (3-4) To recover lectin from the extract derived from Acacia catechu (2-4) above, an appropriate amount of cold ethanol was added to a final concentration of 81%, and the protein containing lectin was precipitated. Was deposited. The precipitate was collected by centrifugation, suspended in 50 mM phosphate buffer (pH 7.2), dialyzed against the same buffer to remove the ethanol, and a crude lectin solution was obtained. Was.
(4) レクチンのゲル濾過による精製  (4) Purification of lectin by gel filtration
(4-1) (3-1) で得られたトゲキリンサイ由来のレクチン粗製液をゲル濾過ク 口マトグラフィ一に供した。 カラムとしてフアルマシア社製 Superdex 75 pgを充 塡した (内径 2 6mm、 充塡長 6 O cm) ものを用いた。 具体的には、 0· 1 IV [の Na C 1を含む 5 OmMのリン酸緩衝液 (pH 7. 2) で緩衝化したこのカラム に(3-1) のトゲキリンサイから抽出したレクチン粗製液を付して、 ゲル濾過カラ ム通過液を UVモニタ一を用いて 28 0 nmにおける吸光度を検出することによ りタンパク質量を測定しながら、 1分間隔で分取し、 同時にヒッジ赤血球を用い て各画分の凝集活性をモニターした。 その結果、 リテンションタイム 6 0分付近 における最も大きなピークと凝集活性のピークとがー致した。 このゲル濾過クロマトグラフィーの結果、 1次抽出液からは約 8 0 Omg、 2 次抽出液からは約 1 6 Omgのトゲキリンサイ由来のレクチンが得られた。 この レクチンは SDS電気泳動 (0.1 %SDS存在下、 1.0 mm厚さの 5〜2 0 %濃 度勾配ポリアクリルアミ ドスラブゲルを用いて、 20mAの定電流で 7 0分間電 気泳動) でシングルバンドを示し、 その純度は(5) 及び(6) 記載の DEAEィォ ン交換クロマトグラフィ一及び分析用ゲル濾過クロマトグラフィ一で測定した結 果、 それぞれ 9 5 %及び 9 9. 9%であった。 また、 抽出液からの回収率は、 赤 血球に対する凝集活性から換算して 9 5%であった。 結局、 1 0 0 gのトゲキリ ンサイ凍結乾燥粉末から 9 6 Omgのトゲキリンサイ由来のレクチンを回収する ことができた。 ゲル濾過クロマトグラフィーにて精製されたこのトゲキリンサイ 由来のレクチンを ES 0とし、 以下の実験に使用した。 以上の結果を図 1に示す。 (4-1) The crude liquid of lectin derived from Rhododendron persica obtained in (3-1) was subjected to gel filtration mouth chromatography. A column packed with 75 pg Superdex manufactured by Pharmacia Co. (inner diameter 26 mm, charged length 6 O cm) was used. Specifically, this column, buffered with 5 · mM phosphate buffer (pH 7.2) containing 0.1 IV [NaCl], was added to the crude lectin solution extracted from the rhododendron (3-1). The protein solution is measured at 280 nm using a UV monitor and the protein content is measured at 1-minute intervals. Each fraction was monitored for agglutination activity. As a result, the largest peak near the retention time of about 60 minutes was coincident with the peak of the aggregation activity. As a result of the gel filtration chromatography, about 80 Omg of lectin derived from Rhododendron was obtained from the primary extract and about 16 Omg from the secondary extract. This lectin was converted to a single band by SDS electrophoresis (electrophoresis in the presence of 0.1% SDS using a 1.0 mm thick 5 to 20% gradient polyacrylamide slab gel at a constant current of 20 mA for 70 minutes). The purity was 95% and 99.9%, respectively, as measured by DEAE ion exchange chromatography and analytical gel filtration chromatography described in (5) and (6). The recovery rate from the extract was 95%, calculated from the agglutinating activity on erythrocytes. In the end, 96 Omg of lectin derived from Rhododendron was obtained from 100 g of the freeze-dried powder. The lectin derived from P. terrestris purified by gel filtration chromatography was designated ES0 and used in the following experiments. Fig. 1 shows the above results.
(4-2) 上記と同様の条件で、 (3-2) で得られたユーキユウマ コッ トニー由 来のレクチン粗製液をゲル濾過クロマトグラフィーに供し、 かつヒッジ赤血球を 用いて各画分の凝集活性をモニターした。  (4-2) Under the same conditions as above, the crude lectin solution derived from Yukiyama Cotney obtained in (3-2) was subjected to gel filtration chromatography, and the agglutination activity of each fraction was determined using hidge erythrocytes. Was monitored.
その結果、 1次抽出液からは約 1 74mg、 2次抽出液からは約 2 Omgの S DS電気泳動 (上記条件と同じ) でシングルバンドを示すレクチンが得られ、 そ の純度は、 (5)及び(6) 記載の DEAEイオン交換クロマトグラフィー及び分析 用ゲル濾過クロマトグラフィーにて、 それぞれ 9 5 %及び 9 7%であった。 また、 抽出液からの回収率は、 赤血球に対する凝集活性から換算して 9 0 %であった。 1 0 0 gのユーキユウマ コットニー凍結乾燥粉末から 20 Omg弱のレクチン が回収された。 ゲル濾過クロマトグラフィーにて精製されたこのレクチンを EC 0とし、 以下の実験に使用した。  As a result, a lectin showing a single band was obtained by SDS electrophoresis (about the same conditions as above) of about 174 mg from the primary extract and about 2 Omg from the secondary extract. ) And (6) were 95% and 97% by DEAE ion exchange chromatography and analytical gel filtration chromatography, respectively. The recovery from the extract was 90%, calculated from the agglutinating activity on erythrocytes. Less than 20 mg of lectin was recovered from 100 g of freeze-dried Yuki Yuma cotney powder. This lectin purified by gel filtration chromatography was designated as EC0 and used in the following experiments.
(4-3) 上記と同様の条件で、 (3-3) で得られたカタメンキリンサイ由来のレ クチン粗製液をゲル濾過クロマトグラフィーに供し、 かつヒッジ赤血球を用いて 凝集活性をモニタ一した。  (4-3) Under the same conditions as described above, the crude lectin solution derived from the red beetle obtained in (3-3) was subjected to gel filtration chromatography, and the agglutinating activity was monitored using hidge erythrocytes.
その結果、 1次抽出液からは約 2 1 Omgの SDS電気泳動 (上記条件と同じ) でシングルバンドを示すカタメンキリンサイ由来のレクチンが得られ、 その純度 は、 (5) 及び(6) 記載の DEAEイオン交換クロマトグラフィー及び分析用ゲル 濾過クロマトグラフィーにて、 それぞれ 9 2%及び 9 3%であった。 また抽出液 からの回収率は、 赤血球に対する凝集活性から換算して 9 0%であった。 1 0 0 gのカタメンキリンサイ凍結乾燥粉末から約 20 Omgのレクチンが回収された。 ゲル濾過クロマトグラフィ一にて精製されたこのレクチンを EG 0とし、 以下の 実験に使用した。 As a result, from the primary extract, a lectin derived from Kamenokirin rhizome showing a single band was obtained by SDS electrophoresis of about 21 Omg (same conditions as above), and the purity was as described in (5) and (6). DEAE ion exchange chromatography and analytical gels By filtration chromatography, they were 92% and 93%, respectively. The recovery from the extract was 90% in terms of the agglutinating activity on erythrocytes. Approximately 200 mg of lectin was recovered from 100 g of the lyophilized powder. This lectin purified by gel filtration chromatography was used as EG0 in the following experiments.
(4-4) 上記と同様の条件で、 (3-4) で得られたアマクサキリンサイ由来のレ クチン粗製液をゲル濾過クロマトグラフィーに供し、 かつヒッジ赤血球を用いて 凝集活性をモニターした。  (4-4) Under the same conditions as described above, the crude lectin solution derived from Amaxilla was obtained in (3-4) was subjected to gel filtration chromatography, and the agglutinating activity was monitored using hidge erythrocytes.
その結果、 1次抽出液からは約 2 1 Omgの SDS電気泳動 (上記条件と同じ) でシングルバンドを示すアマクサキリ 1ンサイ由来のレクチンが得られ、 その純度  As a result, a lectin from Acacia chinensis showing a single band was obtained from the primary extract by SDS electrophoresis of about 21 Omg (same conditions as above).
6  6
は、 (5) 及び(6) 記載の DEAEイオン交換クロマトグラフィー及び分析用ゲル 濾過クロマトグラフィーにて、 それぞれ 9 1 %及び 9 3%であった。 また抽出液 からの回収率は、 赤血球に対する凝集活性から換算して 9 0%であった。 1 0 0 gのアマクサキリンサイ凍結乾燥粉末から約 20 Omgのレクチンが回収された。 ゲル濾過クロマトグラフィーにて精製されたこのレクチンを E A 0とし、 以下の 実験に使用した。 Was 91% and 93% by DEAE ion exchange chromatography and gel filtration chromatography for analysis as described in (5) and (6), respectively. The recovery from the extract was 90% in terms of the agglutinating activity on erythrocytes. Approximately 200 mg of lectin was recovered from 100 g of the lyophilized powder. This lectin purified by gel filtration chromatography was designated as EA0 and used in the following experiments.
(5) DEAEイオン交換クロマトグラフィ一による分画  (5) Fractionation by DEAE ion exchange chromatography
(5-1) (4-1)で得られたトゲキリンサイ由来のレクチン ES 0を DEAEィ オン交換クロマトグラフィーに供した。  (5-1) The lectin ES 0 derived from Rhododendron persica obtained in (4-1) was subjected to DEAE ion exchange chromatography.
具体的には、 ゲル濾過クロマトグラフィーにより得られた ES 0を、 まず 20 mM 炭酸ナトリウム緩衝液 (pH 9. 5) にて透析することにより、 脱塩及び緩衝化 を行った。 カラムとしては TSK— g e 1 DEAE- 5 PW (東ソ一社製、 サ ィズ: 7.5隱 X7.5cm)を用い、 溶離液として溶離液 A (20 mM炭酸ナトリウム緩衝 液、 pH 9.5) および溶離液 B (20 mM炭酸ナトリウム緩衝液, pH 9. 5 +0.5 M 塩化ナトリウム) を用いた。 緩衝化した ES 0を溶離液 Aで平衡化したカラムに 付し、 0— 5分:溶離液 A 1 0 0 %, 5— 4 0分:溶離液 B 0 - 5 0%, 流 速 1. Om 1 i nの条件にてリニアグラジェント (直線型勾配) 溶出を行った。 溶出液のタンパク質含量を 28 0 nmでの吸光度を検出することにより測定し、 同時に溶出画分のヒッジ赤血球に対する凝集活性を測定した。 結果を図 2に示す c その結果、 ES 0より溶出時間の異なる 2つの活性画分が得られた。 それぞれ の画分を ES 1、 ES 2として分取し、 以下の試験に供した。 Specifically, ES 0 obtained by gel filtration chromatography was first desalted and buffered by dialyzing it against a 20 mM sodium carbonate buffer (pH 9.5). Eluent A (20 mM sodium carbonate buffer, pH 9.5) and eluent were used as the eluent, using TSK-ge 1 DEAE-5 PW (manufactured by Tosoichi Co., Ltd., size: 7.5 x 7.5 cm). Solution B (20 mM sodium carbonate buffer, pH 9.5 + 0.5 M sodium chloride) was used. The buffered ES 0 is applied to the column equilibrated with eluent A. 0-5 minutes: eluent A 100%, 5-40 minutes: eluent B 0-50%, flow rate 1. Elution was performed with a linear gradient (linear gradient) under the condition of Om 1 in. The protein content of the eluate was determined by detecting the absorbance at 280 nm, At the same time, the agglutinating activity of the eluted fraction on hedging erythrocytes was measured. The results are shown in FIG. 2c. As a result, two active fractions having different elution times from ES0 were obtained. Each fraction was fractionated as ES 1 and ES 2 and subjected to the following tests.
(5-2) (4-2)で得られたユーキユウマ コッ トニ一由来のレクチン E C 0を 上記と同様の条件にて DE A Eイオン交換クロマトグラフィーに供した。 その結 果、 溶出時間の異なる 2つの活性画分が得られた。 結果を図 3に示す。 それぞれ の画分を EC 1、 EC 2として回収し、 以下の試験に供した。  (5-2) The lectin EC0 derived from Yukiyuma cotoni obtained in (4-2) was subjected to DEAE ion exchange chromatography under the same conditions as above. As a result, two active fractions having different elution times were obtained. The results are shown in Figure 3. Each fraction was collected as EC 1 and EC 2 and subjected to the following tests.
(5-3) (4-3)で得られたカタメンキリンサイ由来のレクチン EG 0を上記と 同様の条件にて DEAEイオン交換クロマトグラフィーに供した。 その結果、 溶 出時間の異なる 3つの活性画分が得られた。 結果を図 4に示す。 それぞれの画分 を EG 1、 EG 2、 及び EG 3として回収し、 以下の試験に供した。  (5-3) The lectin EG0 derived from the red rhinoceros ginseng obtained in (4-3) was subjected to DEAE ion exchange chromatography under the same conditions as described above. As a result, three active fractions having different elution times were obtained. Fig. 4 shows the results. Each fraction was collected as EG1, EG2, and EG3 and subjected to the following tests.
(5-4) (4-3)で得られたアマクサキリンサイ由来のレクチン EA 0を上記と 同様の条件にて D E A Eィォン交換クロマトグラフィ一に供した。 その結果図 5 に示すように、 EA 0より溶出時間の異なる 3つの活性画分が得られた。 それぞ れの画分を E A 1、 EA 2及び EA 3として回収して以下の試験に供した。  (5-4) The lectin EA0 derived from Acacia catechu obtained in (4-3) was subjected to DAE ion exchange chromatography under the same conditions as described above. As a result, as shown in FIG. 5, three active fractions having different elution times from EA0 were obtained. Each fraction was collected as EA1, EA2 and EA3 and subjected to the following tests.
(6) ゲル濾過クロマトグラフィーによる分子量測定  (6) Molecular weight measurement by gel filtration chromatography
(6-1) ES 0および (5-1)で得られた活性画分 ES 1、 E S 2をそれぞれ Superdex 75 HRカラム (10x300nmi)を備したゲル濾過 H P L Cに供して、 各画分 に含まれるレクチンの分子量を測定した。  (6-1) The active fractions ES 1 and ES 2 obtained in ES 0 and (5-1) were subjected to gel filtration HPLC equipped with a Superdex 75 HR column (10x300 nmi), and contained in each fraction. The molecular weight of the lectin was measured.
具体的には、 0.1 Mの Na C 1を含む 0.0 5Mリン酸緩衝液 (pH7.2) にて 緩衝化した上記カラムを用い、 標準タンパク質としてアルドラーゼ (MW1 5 8, 0 0 0) 、 トランスフェリン (MW 8 0, 0 0 0 ) 、 ゥシ血清アルブミ ン (MW 6 8, 0 0 0 ) 、 オボアルブミン (MW4 3, 0 0 0 ) 、 カーボニックアンヒド ラーゼ (MW 32, 0 0 0 ) 、 /5—ラクトグロブリン (MW 1 8 , 0 0 0 ) 、 アブ ロチニン (MW 6, 5 0 0 ) 、 ビタミン B12 (MW 1 , 3 5 5 ) を用いて分子量 を測定した。 その結果: ES 0、 ES 1及び ES 2のいずれもが分子量約 25, 0 0 0であった。  Specifically, using the above column buffered with a 0.05 M phosphate buffer (pH 7.2) containing 0.1 M NaCl, aldolase (MW158, 000), transferrin ( MW 80,000), pepsin albumin (MW 68,000), ovalbumin (MW 43,000), carbonic anhydrase (MW 32,000), / The molecular weight was measured using 5-lactoglobulin (MW18, 000), abrotinin (MW6, 50,000), and vitamin B12 (MW1, 355). Results: All of ES 0, ES 1 and ES 2 had a molecular weight of about 25,000.
(6-2) (6-1)と同様にして、 EC 0および (5- 2)で得られた活性画分 EC 1、 EC 2のそれぞれについてゲル濾過 HP LCによって分子量を測定した。 その結 果、 EC 0、 EC 1及び EC 2のいずれもが分子量約 2 5, 0 0 0であった。 (6-2) In the same manner as (6-1), EC 0 and the active fraction EC 1, obtained in (5-2), Molecular weight was determined by gel filtration HP LC for each of the ECs. As a result, all of EC0, EC1, and EC2 had a molecular weight of about 25,000.
(6-3) (6-1)と同様にして、 EG O及び (5-3)で得られた活性画分 EG 1、 E G 2及び E G 3のそれぞれについてゲル濾過 H P L Cによつて分子量を測定し た。 その結果、 EG 0、 EG 1、 EG 2及び EG 3のいずれもが分子量約 2 5, 0 0 0であった。  (6-3) In the same manner as in (6-1), the molecular weight of each of the active fractions EG1, EG2 and EG3 obtained in EGO and (5-3) was measured by gel filtration HPLC. did. As a result, all of EG0, EG1, EG2 and EG3 had a molecular weight of about 25,000.
(6-4) (6-1)と同様にして、 EA 0及び (5-4)で得られた活性画分 EA 1、 E A 2及び E A 3のそれぞれについてゲル濾過 H PLCによって分子量を測定し た。 その結果、 EA 0、 EAし EA 2及び EA 3のいずれもが分子量約 25, 0 0 0であった。  (6-4) In the same manner as in (6-1), the molecular weight of each of the active fractions EA1, EA2 and EA3 obtained in EA0 and (5-4) was measured by gel filtration HPLC. Was. As a result, EA 0, EA, EA 2 and EA 3 all had a molecular weight of about 25,000.
(7) SDS— PAGEによる分子量測定  (7) Molecular weight measurement by SDS-PAGE
(7-1) SDS— PAGEは、 L a emm l iの方法に従って行った (Nature, 227巻, 680 頁, 1976年) 。 具体的には、 (5-1) で得られた ES 0、 ES 1及び ES 2を 0.5%SDS及び 0.5% 2—メルカプトエタノールの存在下で 1 0 0 °C、 3分間の加熱処理をした後、 0.1 %SDSの存在下で 1. 0 mm厚さの 5〜 20 濃度勾配ポリアクリルアミ ドスラブゲルを用いて電気泳動を行った。 尚、 分子量の測定にはゥシ血清アルブミン (MW 6 6, 0 0 0 ) 、 卵白アルブミン (7-1) SDS-PAGE was performed according to the method of Laemmli (Nature, 227, 680, 1976). Specifically, ES 0, ES 1 and ES 2 obtained in (5-1) were subjected to heat treatment at 100 ° C. for 3 minutes in the presence of 0.5% SDS and 0.5% 2-mercaptoethanol. Thereafter, electrophoresis was carried out using a 1.0-20 mm thick 5-20 concentration gradient polyacrylamide slab gel in the presence of 0.1% SDS. For the measurement of molecular weight, serum albumin (MW 66,000), ovalbumin
(MW 4 5, 0 0 0 ) 、 ゥサギ筋肉由来のグリセルアルデヒド- 3- フォスフェイ トデヒドロゲナ一ゼ (MW 3 6, 0 0 0 ) 、 牛赤血球由来のカーボニックアンヒ ドラ一ゼ (MW2 9, 0 0 0 ) 、 牛脾臓由来のトリプシノーゲン (MW24, 0 0 0) 、 大豆由来のトリプシインヒビター (MW 2 0, 1 0 0 ) 、 牛乳由来のひ ーラクトグロプリン (MW 1 4, 20 0 ) からなる分子量マーカ一を用いた。 夕 ンパク質の染色は、 0.25 %クマ一シ一ブリリアントブルー R-250を含む 7.5 % 酢酸— 5 0 %メタノール混液中で 2時間行い、 脱色は 7.5 %酢酸— 5 %メタノー ルを含む溶液を用いて行った。 (MW 45,000), glyceraldehyde-3-phosphate dehydrogenase derived from rabbit heron muscle (MW 36,000), and carbonic anhydride derived from bovine erythrocytes (MW 29,0 0), trypsinogen derived from bovine spleen (MW 24,000), trypsin inhibitor derived from soybean (MW 20, 100), and heractoglobulin derived from milk (MW 14,200) A molecular weight marker was used. The protein is stained for 2 hours in a mixture of 7.5% acetic acid and 50% methanol containing 0.25% Coomassie Brilliant Blue R-250, and decolorization is performed using a solution containing 7.5% acetic acid and 5% methanol. I went.
この結果、 ES 0、 ES 1及び ES 2のいずれもが分子量約 2 9, 0 0 0であ つた  As a result, all of ES 0, ES 1 and ES 2 had a molecular weight of about 29,000.
(7-2) (7-1)と同様にして SDS— PAGEによって (5-2)で得られた EC 0、 EC 1及び EC 2の分子量を測定した。 その結果、 EC 0、 EC 1及び EC 2のいずれもが分子量約 29, 000であった。 (7-2) EC obtained in (5-2) by SDS-PAGE as in (7-1) The molecular weights of 0, EC 1 and EC 2 were measured. As a result, each of EC 0, EC 1 and EC 2 had a molecular weight of about 29,000.
(7-3) (7-1)と同様にして SDS— PAGEによって (5-3)で得られた EG 0、 EG 1、 EG 2及び EG 3の分子量を測定した。 その結果、 EG0、 EG 1、 EG 2及び EG 3のいずれもが分子量約 29, 000であった。  (7-3) The molecular weights of EG0, EG1, EG2 and EG3 obtained in (5-3) were measured by SDS-PAGE in the same manner as in (7-1). As a result, all of EG0, EG1, EG2 and EG3 had a molecular weight of about 29,000.
(7-4) (7-1)と同様にして SDS— PAGEによって (5-4)で得られた EA 0、 EAし EA 2及び EA 3の分子量を測定した。 その結果、 EA0、 EA 1、 E A 2及び E A 3のいずれもが分子量約 29, 000であった。  (7-4) In the same manner as in (7-1), the molecular weights of EA0, EA, and EA2 and EA3 obtained in (5-4) were measured by SDS-PAGE. As a result, all of EA0, EA1, EA2 and EA3 had a molecular weight of about 29,000.
(8) 等電点電気泳動法による等電点測定  (8) Isoelectric point measurement by isoelectric focusing method
(8-1) ポリアクリルアミ ドゲル等電点電気泳動によって ES 0、 ES 1及び ES 2の等電点測定を行った。 具体的には、 両性担体として 2% Ampholine, pH 4.0〜6.5を用い、 7%ポリアクリルアミ ドゲル中 460 V定電圧にて 20時間 泳動した。 泳動緩衝液として陽極側に 0.0 1 Mリン酸溶液を、 陰極側に 0.0 1 M 水酸化ナトリウム溶液を用いた。 泳動後ゲルを固定染色し、 タンパク質を検出し た。  (8-1) Isoelectric points of ES 0, ES 1 and ES 2 were measured by polyacrylamide gel isoelectric focusing. Specifically, 2% Ampholine, pH 4.0 to 6.5 was used as an amphoteric carrier, and electrophoresis was performed in a 7% polyacrylamide gel at a constant voltage of 460 V for 20 hours. As a running buffer, a 0.01 M phosphoric acid solution was used on the anode side, and a 0.01 M sodium hydroxide solution was used on the cathode side. After electrophoresis, the gel was fixed and stained to detect proteins.
その結果、 等電点は ES 0が p I 4. 75と p i 4. 95、 £ 1が 1 4. 75、 E S 2が p I 4. 95であった。  As a result, the isoelectric points of ES 0 were p I 4.75 and p i 4.95, £ 1 was 14.75, and E S2 was p I 4.95.
(8-2) (8-1)と同様に等電点を測定した。 その結果、 EC (Hip 1 5. 05 と p I 5. 20、 EC 1は p 5. 05および EC 2は p I 5. 20であった。  (8-2) The isoelectric point was measured in the same manner as in (8-1). As a result, EC (Hip 1.55 and pI 5.20, EC1 had p5.05 and EC2 had pI 5.20).
(8-3) (8-1)と同様に等電点を測定した。 その結果、 EGOは p I 4. 95、 p I 5. 20及び p I 5. 50、 EG 1は p 4. 95、 EG2は p I 5. 20、 EG 3は p I 5. 50であった。  (8-3) The isoelectric point was measured in the same manner as in (8-1). As a result, EGO was pI 4.95, pI 5.20 and pI 5.50, EG1 was p4.95, EG2 was pI5.20, and EG3 was pI5.50. .
(8-4) (8-1)と同様に等電点を測定した。 その結果、 EA0は p I 4. 95、 P I 5. 05および p I 5. 20、 EA 1は p 4. 95、 EA2は p I 5. 20、 E A 3は p I 5. 50であった。  (8-4) The isoelectric point was measured in the same manner as in (8-1). As a result, EA0 was pI 4.95, PI 5.05 and pI 5.20, EA1 was p 4.95, EA2 was pI 5.20, and EA3 was pI 5.50.
(9) 糖含量の測定  (9) Measurement of sugar content
(9-1) フエノール硫酸法 CDubois.M. , Gilles.K.A., Hami lton, J. K. ,  (9-1) Phenol sulfate method CDubois.M., Gilles.K.A., Hamilton, J.K.,
Rebers.P.A. and Smith, F. (1956), Anal.C em. 28, 357〕 により、 ES 0、 E S 1及び ES 2に含まれる糖量を測定した。 糖量の測定標準試料としてグルコ一 スを用いた。 夕ンパク質量の測定はバイオラッド社の DCプロティンアツセィキ ッ トを使用して行った。 なお、 糖含量は以下の式にて求めた。 Rebers.PA and Smith, F. (1956), Anal.Cem. 28, 357], ES 0, E The amount of sugar contained in S1 and ES2 was measured. Glucose was used as a standard sample for measuring the amount of sugar. The evening mass was measured using a Bio-Rad DC Protein Atskit. The sugar content was determined by the following equation.
{糖量ノ (タンパク質量 +糖量) } X 1 0 0 =糖含量 (%)  {Sugar content (protein content + sugar content)} X 100 = sugar content (%)
その結果、 ES 1が 0.0 1 %、 ES 2が 0.0 2%であり、 トゲキリンサイ由来 のレクチンは糖鎖を有しないと考えられる。 なお、 ES 0については再現性のあ るデータが得られなかつた。 これは精製の過程で該レクチンとは無関係の糖類が わずかに混入したままの場合があるためと考えられる。  As a result, ES1 was 0.01% and ES2 was 0.02%, and it is considered that the lectin derived from Togekirinsai has no sugar chain. For ES0, reproducible data was not obtained. This is presumably because saccharides unrelated to the lectin may remain slightly mixed during the purification process.
(9-2) (9-1)と同様にして、 EC 0、 EC 1及び EC 2の糖含量を求めた結 果、 糖含量は E C 0が 0.5 %、 E C 1が 0.0 3 %及び E C 2力 0.0 2 %であった c これより、 ユーキユウマ コッ トニ一由来のレクチンは糖鎖を有しないと考えら れる。 (9-2) The sugar content of EC 0, EC 1 and EC 2 was determined in the same manner as in (9-1) .The sugar content was 0.5% for EC 0, 0.03% for EC 1 and EC 2 Based on the fact that the power was 0.02% c, it is considered that the lectin derived from Equine cotonia has no sugar chain.
(9-3) (9-1)と同様にして、 EG 1、 EG 2及び EG 3の糖含量を求めた結 果、 糖含量は EG 1が 0.1 5%、 EG 2が 0.0 1 %及び EG 3が 0.0 1 %であつ た。 これより、 カタメンキリンサイ由来のレクチンは糖鎖を有しないと考えられ る o  (9-3) The sugar content of EG1, EG2 and EG3 was determined in the same manner as in (9-1) .The sugar content was 0.15% for EG1, 0.01% for EG2 and 3 was 0.01%. Based on this, it is considered that the lectin derived from Rhinoceros ginseng has no sugar chain.o
(9-4) (9-1)と同様にして、 EA 1、 E A 2及び E A 3の糖含量を求めた結 果、 糖含量は E A 1が 0.1 5 %、 E A 2が 0.0 1 及び E A 3が 0.0 1 %であつ た。 これより、 アマクサキリンサイ由来のレクチンは糖鎖を有しないと考えられ る。  (9-4) The sugar content of EA1, EA2, and EA3 was determined in the same manner as in (9-1) .The sugar content was 0.15% for EA1, 0.01 for EA2, and EA3. Was 0.01%. From this, it is considered that the lectin derived from Amacakirinsai has no sugar chain.
(10) N末端領域のァミノ酸配列分析  (10) Amino acid sequence analysis of N-terminal region
トゲキリンサイ由来のレクチン (ES 0、 ES 1及び ES 2) 、 ユーキユウマ コッ トニー由来のレクチン (EC 0、 EC 1及び EC 2) 、 力夕メンキリンサイ 由来のレクチン (EG 0、 EG 1、 EG 2及び EG 3) 由来のレクチンおよびァ マクサキリンサイ由来のレクチン (EA 0、 EA 1、 EA 2及び EA 3) それぞ れを Applied Biosystems 477A PTHアナライザーに供し、 N末端から 1 q残基ま でのァミノ酸配列を分析した。  Lectins derived from Papaver rhinoceros rhinoceros (ES 0, ES 1 and ES 2), lectins derived from Yuki-Yuma Cotney (EC 0, EC 1 and EC 2), and lectins derived from Papaver rhinoceros rhinoceros (R. EG 3) -derived lectin and Amaxilla lectin-derived lectins (EA 0, EA 1, EA 2 and EA 3) were applied to an Applied Biosystems 477A PTH analyzer, and amino acids from the N-terminus to 1q residue were analyzed. The sequence was analyzed.
その具体的な結果を下表に示すが、 いずれのレクチンについても、 N末端より 1 0残基のアミノ酸配列は Gly-Arg-Tyr-Thr-Val-X-Asn-Gln- Trp-Glyであり、 X で示される N末端から 6番目のァミノ酸がグル夕ミンかリジンであるかを除いて 同一であった。 The specific results are shown in the table below. The amino acid sequence of 10 residues is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly, and the sixth amino acid from the N-terminal indicated by X is glumin or lysine. Were identical except for
ES 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly ES 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
ES 2 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly  ES 2 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
EC 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly  EC 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
EC 2 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly  EC 2 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
EG 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly  EG 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
EG 2 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly  EG 2 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly
EG 3 Gly-Arg- Tyr-Thr-Val-し ys - Asn- Gln-Trp-Gly  EG 3 Gly-Arg- Tyr-Thr-Val- ys-Asn-Gln-Trp-Gly
E A 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly  E A 1 Gly-Arg- Tyr-Thr-Val- Gln-Asn- Gln-Trp-Gly
EA 2 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly  EA 2 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly
EA 3 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly  EA 3 Gly-Arg- Tyr-Thr-Val- Lys-Asn- Gln-Trp-Gly
(11) 種々の赤血球に対する凝集活性 (11) Agglutinating activity on various erythrocytes
トゲキリンサイ由来のレクチン (ES 0、 ES I及び ES 2) 、 ユーキユウマ コッ トニー由来のレクチン (ECO、 EC 1及び EC 2) 、 力夕メンキリンサイ 由来のレクチン (EG0、 EG 1、 EG2及び EG3) 由来のレクチンおよびァ マクサキリンサイ由来のレクチン (EA0、 EA 1、 EA2及び EA3) それぞ れについて、 各種赤血球に対する凝集活性を測定した。 赤血球として、 ゥサギ赤 血球、 ヒッジ赤血球、 ゥマ赤血球、 ガチョウ赤血球、 トリプシン処理ゥサギ赤血 球、 トリプシン処理ヒッジ赤血球、 トリプシン処理ゥマ赤血球及びトリプシン処 理ガチョウ赤血球を用いた。 測定は連続 2倍希釈法 CBOTANICA MARINA, 第 31巻、 第 133-138頁、 (1988)〕 にて行った。 結果を表 1に示す。 上記の各キリンサイ属 由来のレクチンは海藻の種類に関係なく、 いずれもヒッジ赤血球、 トリプシン処 理ゥサギ赤血球及びトリプシン処理ヒッジ赤血球を特異的に凝集させることが確 認された。 表 1 種々の赤血球に対するキリンサイ属海藻由来のレクチンの凝集活性 Lectins derived from Papaver rhinoceros rhinoceros (ES 0, ES I and ES 2), lectins derived from Yucca cotonii (ECO, EC 1 and EC 2), and lectins derived from Papaver rhinoceros rhinoceros rhinoceros (Rice chinensis) (EG0, EG1, EG2 and EG3) The agglutinating activity on various erythrocytes was measured for each of the lectin and the lectins (EA0, EA1, EA2 and EA3) derived from Rhododendron. Erythrocytes, sheep erythrocytes, ゥ erythrocytes, goose erythrocytes, trypsin-treated ギ heron erythrocytes, trypsin-treated hedge erythrocytes, trypsin-treated ゥ erythrocytes, and trypsin-treated geese erythrocytes were used as erythrocytes. The measurement was carried out by the continuous two-fold dilution method CBOTANICA MARINA, Vol. 31, pp. 133-138, (1988)]. Table 1 shows the results. It was confirmed that the lectins derived from each of the above-mentioned Kirinsai genera specifically agglutinate hedged erythrocytes, trypsin-treated heron erythrocytes, and trypsin-treated shed erythrocytes, regardless of the type of seaweed. Table 1 Agglutinating activity of lectins from the genus Giraffe on various erythrocytes
Figure imgf000024_0001
Figure imgf000024_0001
+ :赤血球凝集活性あり - :赤血球凝集活性なし  +: Hemagglutination activity-: No hemagglutination activity
(12) 糖結合特異性 (12) Sugar bond specificity
トゲキリンサイ由来のレクチン (ES 0 ES 1及び ES 2) 、 ユーキユウマ コッ トニ一由来のレクチン (EC 0 EC 1及び E C 2) 、 カタメンキリンサイ 由来のレクチン (EG0 EG 1 EG2及び EG3) 由来のレクチンお'よびァ マクサキリンサイ由来のレクチン (EA0 E A 1 EA2及び EA3) それぞ れについて糖結合特異性を調べた。 具体的には、 まず表 2に列記する種々の単糖、 オリゴ糖及び配糖体について、 様々な濃度溶液を調製し、 それらの溶液それぞれに最小凝集濃度に調製した各レ クチンを加えて室温で 2時間反応させた。 次いで、 それらの中にヒッジ赤血球を 添加し、 該ヒッジ赤血球の凝集反応を調べて、 各レクチンの赤血球に対する凝集 活性を阻止する糖濃度を求めて、 各レクチンの糖結合特異性を判断した。 Lectins derived from Rhododendron ginseng (ES 0 ES 1 and ES 2), Lectins derived from Echinoma crispina (EC 0 EC 1 and EC 2), and Lectins derived from Lactobacillus reticulata (EG0 EG 1 EG2 and EG3) And the lectins (EA0 EA1 EA2 and EA3) derived from Acacia chinensis were examined for their sugar-binding specificity. Specifically, first prepare various concentration solutions of various monosaccharides, oligosaccharides and glycosides listed in Table 2, add each lectin adjusted to the minimum aggregation concentration to each of these solutions, and add to room temperature. For 2 hours. Next, hedged erythrocytes were added to them, the agglutination of the hedged erythrocytes was examined, and the sugar concentration that inhibits the agglutinating activity of each lectin on erythrocytes was determined to determine the sugar-binding specificity of each lectin.
トゲキリンサイ由来、 ユーキユウマ コッ トニー由来、 力タメンキリンサイ由 来およびアマクサキリンサイ由来のレクチンの各分画について、 種々の糖が凝集 反応を 5 0 %阻止するために要する濃度 ( g Zm l ) を表 2に合わせて示す。 The concentrations (gZml) required for various sugars to inhibit the agglutination reaction by 50% are shown for the fractions of lectins derived from Rhododendron rhinoceros, Yukiyuma cotney, Rhododendron rhinoceros rhinoceros and Akumasakirin rhinoceros. Shown along with 2.
表 2 キリンサイ属海藻由来のレクチンの糖結合特異性 糖関係物質 トケ'キリンサイ t. cottonn カタメンキリンサイ アマクサキリンサイ Table 2 Sugar-binding specificity of lectins derived from the genus Kirinsai seaweed Sugar-related substances Toke'Kirinsai t. Cottonn
ES0 ES1 ES2 ECO EC1 EC2 EGO EG1 EG2 EG3 EA0 EA1 EA2 EA3 ES0 ES1 ES2 ECO EC1 EC2 EGO EG1 EG2 EG3 EA0 EA1 EA2 EA3
L-ァラヒ -ス L-arahi
ドォキシク'ルコ-ス  Doxyk Rucos
D-フルクト-ス  D-Fructose
力'ラクトス  Force 'Lactos
N-ァセチルカ'ラクト-ス  N-acetylka 'lactose
D-力'ラクフロン酸  D-force 'racfuronic acid
N-ァセチル ルコ-ス  N-Acetyl Rucos
• D-ク 'ルクロン酸  • D-Curcuronic acid
D-ク'ルコ-ス  D-Courcouse
D-ク'ルコ-ス 6リン酸  D-Culcose 6-phosphate
ラクト-ス  Lactose
マルトース  Maltose
マンニ卜ール  Mannitol
D-マンノ-ス  D-Mannose
D-メリヒ'; ί-ス  D-Merich ';
D-ラフィノ-ス  D-raffinos
L-ラムノ-ス  L-rhamnoth
D-リホ' -ス  D-Riho '
キジ D-ス  Pheasant D-s
a 1一 a one
ァシ 7卩グリコプ Dティン 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 100Ό 1000 フエチン 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 125 62.5 62.5 62.5 125 ァシ了 0フエチン 31.3 31.3 31.3 31.3 31.3 31.3 31.3 31.3 31.3 125 31.3 31.3 31.3 125 チロク 'ロフ 'リン 3.9 3.9 3.9 3.9 3.9 3.9 3.9 0 3.9 7.8 3.9 1.0 3.9 7.8 ィ-ストマンナン 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 15.6 31.3 3.9 3.9 15.6 31.3 早位: a g/m 1 凝集阻害なし いずれのレクチンも、 単糖及びオリゴ糖に対しては特異的な結合を示さず、 ァ シァロフエチン、 フエチン、 チログロブリンおよびイーストマンナンに対して結 合特異性を有し、 1—ァシッ ドグリコプロティンに対しても弱い結合特異性を 示した。 中でもチログロブリン、 イーストマンナンに対しては、 特に強い結合特 異性を示した。 Ash 7 gar glyco D tin 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 100 フ 1000 fuetin 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 62.5 125 62.5 62.5 62.5 125 ash 0 fuetin 31.3 31.3 31.3 31.3 31.3 31.3 31.3 31.3 31.3 125 31.3 31.3 31.3 125 Chiroc 'Lof' phosphorus 3.9 3.9 3.9 3.9 3.9 3.9 3.9 0 3.9 7.8 3.9 1.0 3.9 7.8 Diestmannan 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 3.9 15.6 31.3 3.9 3.9 15.6 31.3 Early: ag / m 1 Aggregation No inhibition Neither lectin shows specific binding to monosaccharides and oligosaccharides, has binding specificity for asialophetin, phytin, thyroglobulin and yeast mannan, and binds to 1-acid glycoprotein. It also showed weak binding specificity. Among them, thyroglobulin and yeast mannan exhibited particularly strong binding characteristics.
これらのことから、 上記の各キリンサイ属由来のレクチンは糖タンパク質の N- グリコシド型糖鎖を認識し、 特にその中でも高マンノース型を強く認識すること がわかった。  From these facts, it was found that the lectins derived from each of the above-mentioned Kirinsai genera recognize N-glycoside type sugar chains of glycoproteins, and particularly strongly recognize high mannose type among them.
試験例 1 トゲキリンサイ属由来、 ユーキユウマ コッ トニ一由来、 カタメンキ リンサイ由来およびアマクサキリンサイ由来のレクチンのマウス及びヒトリンパ 球に対する幼若化活性の測定試験 Test Example 1 Measurement test of the blastogenic activity of mouse and human lymphocytes of lectins derived from Rhododendron spp.
(a) マウスリンパ球に対する幼若化活性の測定  (a) Measurement of blastogenic activity on mouse lymphocytes
マウス (BALBZC, 雌、 1 7週令) 脾臓より、 常法に従いリンパ球画分を 取得し、 これを 1 0 %牛胎児血清含有 RPM I 1 640培地で 3回洗浄後、 5 x Mouse (BALBZC, female, 17-week-old) A lymphocyte fraction was obtained from the spleen according to a conventional method, and washed three times with RPMI 1640 medium containing 10% fetal calf serum.
1 06 細胞 Zm 1濃度のリンパ球懸濁液を調製した。 この懸濁液 1 00 1 に各 濃度に調製した各キリンサイ由来のレクチンを含む RPM 1 1 640培地 100〃1 を加え、 同培地中 5%C02 下 37°Cで培養した。 培養 50時間後、 3H-チミ ン1 0 6 lymphocyte cell suspension Zm 1 concentration was prepared. The suspension 1 00 RPM 1 1 640 medium 100〃1 added containing lectin from each Eucheuma prepared to each concentration in 1, were cultured in 5% C0 2 under 37 ° C in the same medium. After culturing for 50 hours, 3 H- thymine
(0.5 C iZl 0 /1 ) を添加し、 更に 6時間培養した。 この培養液中の培養 細胞をセルハーべスタを用いてガラス状繊維フィルター (Whatman)上に回収し、 乾燥後、 カウンティングバイアルに入れ、 液体シンチレ一シヨンカウンタ一でリ ンパ球に取り込まれた3 H-チミジン量を測定した。 放射線取り込み量から、 ステ ィ ミュレ一ションィンデックスを調べたところ、 トゲキリン'サイ由来のレクチン(0.5 CiZl 0/1) was added, and the cells were further cultured for 6 hours. The cultured cells of the culture medium was collected on a glass-like fiber filter (Whatman) using a static base Seruha, dried, placed in a counting vial, 3 H incorporated into lymphocytes in liquid scintillation one Chillon counter one -The amount of thymidine was measured. Examination of the steady-state index from the amount of radiation uptake revealed that the lectin from Togekirin 'rhinoceros
(ES 0、 ES 1及び ES 2) 、 ュ一キユウマ コッ トニー由来のレクチン (E C 0、 EC 1及び EC 2) 、 カタメンキリンサイ由来のレクチン (EG 0、 EG 1、 EG2及び EG3) およびアマクサキリンサイ由来のレクチン (EA0、 E A l、 EA2及び EA3) はいずれも、 マウスリンパ球幼若化活性を有すること が認められた。 (ES 0, ES 1 and ES 2), lectin from E. cucumber (EC 0, EC 1 and EC 2), lectin from katamenokirin (EG0, EG1, EG2 and EG3) and from Akumasakirinsai All lectins (EA0, EAl, EA2 and EA3) were found to have mouse lymphocyte blastogenesis activity.
(b) ヒトリンパ球に対する幼若化活性の測定 ヒト血液より密度勾配遠心法によって 5 X 1 06 細胞 Zm 1濃度のヒト末梢血 液由来のリンパ球懸濁液を調製した。 この懸濁液 1 0 0 1 に各濃度に調製した 各キリンサイ由来のレクチンを含むを RPM 1 1 64 0培地 1 0 0〃1 を加え、 同培地中 5 % C 02 下 37 °Cで培養した。 培養 5 0時間後、 3H-チミジン ( 0.5 i/1 0 u\ ) を添加し、 更に 6時間培養した。 この培養液中の培養細胞を セルハーべスタを用いてガラス状繊維フィルター(Whatman) 上に回収し、 乾燥後、 カウンティングバイアルに入れ、 液体シンチレーションカウンターでリンパ球に 取り込まれたい -チミジン量を測定した。 放射線取り込み量からスティ ミュレ一 シヨンインデックスを調べたところ、 トゲキリンサイ由来のレクチン (ES 0、 ES 1及び ES 2) 、 ユーキユウマ コッ トニ一由来のレクチン (EC 0、 EC 1及び E C 2) 、 カタメンキリンサイ由来のレクチン (EG 0、 EGし EG 2 及び EG 3) およびアマクサキリンサイ由来のレクチン (EA 0、 EA 1、 EA 2及び E A 3) はいずれもヒトリンパ球に対して幼若化活性を有することが認め られた。 (b) Measurement of blastogenic activity on human lymphocytes A lymphocyte suspension derived from human peripheral blood at a concentration of 5 × 10 6 cells Zm 1 was prepared from human blood by density gradient centrifugation. The suspension 1 0 0 1 to the lectin from each Eucheuma prepared to each concentration RPM 1 1 64 0 Medium 1 0 0〃1 added, cultured at 5% C 0 2 under 37 ° C in the same medium did. After 50 hours of culture, 3 H-thymidine (0.5 i / 10 u \) was added, and the cells were further cultured for 6 hours. The cultured cells in this culture solution were collected on a glass fiber filter (Whatman) using a cell harvester, dried, placed in a counting vial, and incorporated into lymphocytes using a liquid scintillation counter. The amount of thymidine was measured. . Examination of the stimulation index based on the amount of radiation uptake revealed that the lectins derived from the rhododendron (ES0, ES1, and ES2), the lectins (Ec0, EC1, and EC2) from the eastern fox, the catkin giraffe, Lectins derived from EG0, EG and EG2 and EG3 and lectins derived from Acacia chinensis (EA0, EA1, EA2 and EA3) may have blastogenic activity on human lymphocytes. Admitted.

Claims

請求の範囲 The scope of the claims
1. 以下の特徵を有するレクチン:  1. Lectin with the following features:
(a) ゲル濾過法による分子量が約 25, 000であり、  (a) the molecular weight by gel filtration is about 25,000,
(b) SDS電気泳動法による分子量が約 29, 000であり、  (b) the molecular weight by SDS electrophoresis is about 29,000,
(c) 等電点電気泳動法による等電点が p I 4. 5〜p I 5. 7の範囲にあり、 (c) the isoelectric point by isoelectric focusing is in the range of pI4.5 to pI5.7,
(d) 糖鎖を持たず、 (d) has no sugar chain,
(e) N末端領域のアミノ酸配列が、 Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (Xは Ginあるいは Lys)であり、  (e) the amino acid sequence of the N-terminal region is Gly-Arg-Tyr-Thr-Val-X-Asn-Gln-Trp-Gly (X is Gin or Lys),
(f) トリプシン処理ゥサギ赤血球、 ヒッジ赤血球及びトリプシン処理ヒッジ赤血 球に対して特異的な凝集活性を有し、  (f) Trypsin-treated ギ has specific agglutinating activity on heron erythrocytes, sheep erythrocytes and trypsin-treated sheep erythrocytes,
(g) フエチン、 ァシァ口フエチン、 チロク "ロブリン及びイーストマンナンに対し て結合特異性を示す。  (g) Shows binding specificity for phytin, asia-mouth phytin, thyroxine, roblin and yeast mannan.
2. 等電点電気泳動法による等電点が p 1 4. 75、 p I 4. 95、 p I 5. 05 p i 5. 20および p i 5. 50からなる群から選ばれる少なくとも 1つで ある請求の範囲第 1項記載のレクチン。 2. The isoelectric point by isoelectric focusing is at least one selected from the group consisting of p1 4.75, pI4.95, pI5.05 pi5.20 and pi5.50 The lectin according to claim 1.
3. 海藻に由来するものであることを特徴とする請求の範囲第 1項または第 2項 のいずれかに記載のレクチン。 3. The lectin according to claim 1, wherein the lectin is derived from seaweed.
4. 海藻がキリンサイ属 (Eucheuma属または Kappaphycus属) に属することを特 徵とする請求の範囲第 3項のレクチン。 4. The lectin according to claim 3, wherein the seaweed belongs to a genus Kirinsai (genus Eucheuma or Kappaphycus).
5. キリンサイ属に属する海藻がトゲキリンサイ (Eucheuma serra), ユーキュ ゥマ コッ トニー (EuGheuma cottonii) 、 カタメンキリンサイ (Eucheuma gelatinae)—及びアマクサキリンサイ (Eucheuma ^nakusaensis) からなる群 から選択されるレ、ずれか一つであることを特徴とする請求の範囲第 4項のレ クチン。 5. The seaweed belonging to the genus Giraffe is selected from the group consisting of Eucheuma serra, EuGheuma cottonii, Eucheuma gelatinae and Eucheuma ^ nakusaensis. 5. The lectin according to claim 4, wherein the lectin is at least one.
6. キリンサイ属 (Eucheuma属または Kappaphycus 属) に属する海藻を、 緩衝液 及び溶媒一水混合液から選ばれるいずれかの抽出溶媒で抽出し、 その抽出液 を溶媒沈殿及びゲル濾過の工程を経ることによつて分離精製することを特徴 する請求の範囲第 1項または第 2項に記載のレクチンの製造方法。 6. Extract seaweeds belonging to the genus Kirinsai (genus Eucheuma or Kappaphycus) with an extraction solvent selected from a buffer and a solvent-water mixture, and subject the extract to solvent precipitation and gel filtration. 3. The method for producing a lectin according to claim 1, wherein the lectin is separated and purified.
7. ゲル濾過後、 さらにイオン交換クロマトグラフィーに付すことを特徴とする 請求の範囲第 6項記載のレクチンの製造方法。 7. The method for producing a lectin according to claim 6, further comprising subjecting the gel filtration to ion exchange chromatography.
8. 得られるレクチンが p 1 4. 75、 p I 4. 9 5、 p I 5. 0 5. p I 5. 2 および p I 5. 5からなる群から選択される少なくとも一つの等電点を有す るものであることを特徴とする請求の範囲第 6項または第 7項記載のレクチ ンの製造方法。 8. at least one isoelectric point whose lectin is selected from the group consisting of p1 4.75, pI4.95, pI5.0, pI5.2 and pI5.5 8. The method for producing a lectin according to claim 6 or 7, wherein the method comprises:
9. 抽出および溶媒沈澱で用いられる溶媒のいずれかが、 アセトン、 メタノール、 エタノール及びィソプロパノールからなる群から選択されるいずれか一つで ある請求の範囲第 6〜 8項のいずれかに記載のレクチンの製造方法。 9. The method according to any one of claims 6 to 8, wherein any one of the solvents used in the extraction and the solvent precipitation is any one selected from the group consisting of acetone, methanol, ethanol, and isopropanol. Production method of lectin.
1 0. 抽出および溶媒沈澱で用いられる溶媒のいずれかが、 エタノールである請 求の範囲第 6〜 8項のいずれかに記載のレクチンの製造方法。 10. The method for producing a lectin according to any one of claims 6 to 8, wherein one of the solvents used in the extraction and the solvent precipitation is ethanol.
PCT/JP1994/002140 1993-12-24 1994-12-19 Novel lectin and process for producing the same WO1995018149A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7516400A JP2895962B2 (en) 1993-12-24 1994-12-19 Novel lectin and method for producing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32821893 1993-12-24
JP5/328218 1993-12-24

Publications (1)

Publication Number Publication Date
WO1995018149A1 true WO1995018149A1 (en) 1995-07-06

Family

ID=18207773

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1994/002140 WO1995018149A1 (en) 1993-12-24 1994-12-19 Novel lectin and process for producing the same

Country Status (1)

Country Link
WO (1) WO1995018149A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03279396A (en) * 1990-03-29 1991-12-10 Agency Of Ind Science & Technol Rhodophyceae lectin and production thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03279396A (en) * 1990-03-29 1991-12-10 Agency Of Ind Science & Technol Rhodophyceae lectin and production thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOTANICA MARINA, Vol 31, Fasc. 2, 1988 (88), K. HORI et al., pages 133-138. *
JOURNAL OF APPLIED PHYCOLOGY, Vol. 5, No. 2, April 1993, K.T. BIRD et al., pages 213-218. *

Similar Documents

Publication Publication Date Title
Leach et al. Hydroxyproline-rich bacterial agglutinin from potato: extraction, purification, and characterization
Mahieu et al. Chemical structure of tubular and glomerular basement membranes of human kidney: Isolation, purification, carbohydrate and amino acid composition
Suzuki et al. Purification and characterization of two lectins from Aloe arborescens Mill
KEKOMAKI et al. Alkali-stable blood group A-and B-active poly (glycosyl)-peptides from human erythrocyte membrane
Molnar et al. The role of an α2-macroglobulin of rat serum in the phagocytosis of colloidal particles
Davie et al. Chemical characterization of glycopeptides from human γM-globulins
EP0475383B1 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
WO1995018149A1 (en) Novel lectin and process for producing the same
US3558433A (en) Process for purification of chymopapain
Peumans et al. Isolation and partial characterization of a new lectin from seeds of the greater celandine (Chelidonium majus)
CN108410936A (en) A kind of buffalo's milk anti-oxidation peptide and its method for separating and preparing
Wagner Interaction of wheat-germ agglutinin with streptococci and streptococcal cell wall polymers
CN101724029B (en) Anti-tumor protein and preparation method and application thereof
JP2895962B2 (en) Novel lectin and method for producing the same
Toda et al. Characterization of the lectin from the skin mucus of the kingklip Genypterus capensis
US20060078569A1 (en) Method for recovery of photo-inhibited immunological activity
JP2005526142A (en) Preparation and standardization of immunomodulating peptide-binding glucan with verifiable oral absorption obtained from Coriolis versatile
KR100379189B1 (en) Agents for gastroenteric disorder by Helicobacter pylori and screening method thereof
KR100468649B1 (en) Anti-complementary biopolymer from fruiting body of Coriolus versicolor and method for isolation thereof
JPH0768135B2 (en) Botulinum toxin neutralizer
RU2065876C1 (en) Process for recovering enzyme agent from muscle tissue of fish
JP3041598B2 (en) Seaweed lectin and method for producing the same
CN86100551A (en) The method of purification of superoxide dismutase (SOD)
WO2000027876A1 (en) Method for the isolation of lectins and the obtained purified lectins for use as a medicament
Ohsawa et al. Purification and properties of a β-galactoside-binding lectin from neonatal marmoset

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP KR US VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA